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 RESUME
 
La  résistance  pléïotropique  aux  médicaments  est  l'un  des  obstacles  majeurs 
limitant  l'utilisation  de  la  chimiothérapie  comme  possibilité  thérapeutique 
anticancéreuse. Bien que non totalement élucidé, ce phénomène de résistance observé a 
été associé  à  la  surexpression d'une  protéine de  170kDa,  appartenant à  la  classe  des 
protéines  de  transport  ABC,  ATP  dépendante.  Il  a  été  démontré  que  les  cellules 
surexprimant la MDR développent également un  phénomène de résistance à l'induction 
de  l'apoptose  rendant  ainsi  les  essais  de  sensibilisation  des  cellules  résistantes  aux 
médicaments et les recherches menées pour cette fin  très avantageux et louables pour la 
thérapie anti-cancer. 
Dans  la  présente étude  nous  avons  investigué la  possibilité de  l'induction  de 
l'apoptose chez des  cellules de  l'ovaire de hamster chinois surexprimants la  protéine 
MOR (CHü MOR CHRCS)  et des cellules parentales ne développant pas  la  résistance 
pléïotropique  aux  médicaments  (CHü  AuxB 1)  par  le  choc  thermique.  Pour  mieux 
comprendre ce phénomène de résistance, nous nous sommes intéressé en particulier, à la 
voie du récepteur de mort Fas et à la voie intrinsèque médiée par la mitochondrie. Nos 
résultats montrent que le choc thermique (40-43°C) active les caspases initiatrices 9 et 8 
ainsi que les caspases effectrices 3, et 7.  Contrairement aux cellules AuxB l, les cellules 
CHRCS exhibent une résistance à l'induction de la voie du récepteur de mort Fas par le 
choc thermique. La voie intrinsèque, quant à elle, est induite pareillement chez les deux 
lignées  cellulaires.  De  plus,  la  translocation  de  Bax  et  du  Bid  tronqué  (tBid)  à la 
mitochondrie était responsable de la pennéabilisation de la membrane mitochondriale et 
par conséquent la libération du cytochrome c et l'activation des caspases 9 et 3 chez les 
deux lignées cellulaires. Le clivage des substrats de la caspase 3 (JCAD et PARP) était 
similaire chez les deux modèles cellulaires, suggérant que les cellules MDR CHRCS sont 
non  résistantes au  choc thennique. Toutefois, cette étude est la  première à investiguer 
les  mécanismes  moléculaires  de  l'apoptose  induite  par le  choc  thennique  chez  des 
cellules surexprimants la  protéine MOR et à conjecturer le  rôle de l'hyperthennie dans 
la lutte contre la résistance pléïotropique aux médicaments en médicine clinique. 
Mots-clefs:  Hyperthermie,  Résistance  pléiotropique,  P-glycoproteine,  Apoptose, 
Cellules. ABSTRACT 
Multidrug  resistance  (MDR)  is  a  major  obstacle  Iimiting  the  use  of 
chemotherapy  in  cancer  treatment.  The  MDR  phenotype  has  been  associated  with 
overexpression  of an  ATP-dependent  membrane efflux  pump,  P-glycoprotein.  It  has 
been  suggested  that  MDR  ceIls,  aside  from  resistance  to  chemotherapy,  might  also 
inhibit  apoptosis  at  a variety  of levels  within  the  death  signalling  pathways.  Thus, 
reversaI of resistance or sensitization of the MDR cells to  chemotherapeutic drugs  as 
weIl  as  the  induction of apoptosis  in  MDR cells are  essential  parts  of the  search  for 
more successful treatments of cancer. 
This  study  investigates  the  induction  of  apoptosis  in  MDR  CHRCS  cells  in 
comparison to their parental, drug sensitive AuxBl Chinese hamster ovary cells, using 
heat  shock  to  sensitize  the  cells.  We  assessed  the  responses  of  MDR  and  drug 
sensitive  cells  to  death  receptor  and  rnitochondria  mediated  signalling  pathways  of 
apoptosis  in  order  to  investigate  possible  mechanisms  of  resistance  to  heat  shock 
induced ceIl  death.  Our findings  showed that  in  CHRCS  cells the  receptor mediated 
pathway appears to confer sorne resistance to heat shock (40-43°C) induced apoptosis 
with  decresed  levels  of the  Fas-associated death  domain  (FADD)  protein,  increased 
levels of antiapoptotic protein c-FLIP and a low  level of caspase-8 activation by heat. 
Heat shock induced apoptosis to a similar extent in CHRCS cells via the mitochondria 
mediated  signalling  pathway  with  Bax  translocation  to  the  mitochondria, 
rnitochondrial  membrane  depoJarization,  release  of cytochrome  c  and  activation  of 
caspase-9  and  -3.  Also,  similar  levels  of  cleavage  of  downstream  substrates  of 
caspase-3  were observed in  the  two  ceIl  lines  suggesting that  overall, MDR CHRCS 
cells are not resistant to heat shock induced apoptosis.  This study reveals, for the first 
time,  the  major  molecular  mechanisms  of  heat  shock  induced  apoptosis  in  MDR 
tumor.  The results  imply that  hyperthermia is  a promising method  used  to  irradicate 
MDR tumor cells in the clinic. 
Keywords: Multidrug resistance, P-glycoprotein, Heat shock, Apoptosis, Caspases, 
Cel!. CHAPTER 1:  INTRODUCTION 
1.1. CANCER 
1.1.1. OVERVIEW 
Cancer is  a  disease characterized by  an  uncontrollable proliferation of ce\ls 
and  the  ability  of those  cel1s  to  invade  other tissues,  either by direct growth  into 
adjacent  tissues  (invasion)  or  by  migration  of  cells  to  distant  sites  (metastasis) 
(Rubin, 2001).  The unregulated growth of cancer cells can be caused by a number of 
factors,  which ultimately result in the sequential acquisition of somatic mutations in 
genes  that  control  cell  growth  and  differentiation  or are  involved  in  DNA  repair. 
Mutations may be present in  the germline, produced by environmental mutagens or 
arise  as  a  consequence of normal  cellular metabolism.  Genes  involved  in  cancer 
pathogenesis  can  be  grouped  into  three  categories:  oncogenes,  tumor  suppressor 
genes and DNA repair genes.  Oncogenes are the altered versions of normal proto­
oncogenes, which regulate normal cell growth and differentiation.  Tumor suppressor 
genes  are  normal  genes  whose products inhibit cellular proliferation.  DNA repair 
genes  function  to  maintain  the  integrity  of  the  genome  and  fidelity  of  DNA 
replication.  Mutations in  these genes offset the mechanisms controlling cell division 
and repair and usually lead to the formation of a tumor (Bannasch, 1998). 
A tumor refers to any abnormal mass of tissue and may be either benign (non­
cancerous) or malignant (cancerous).  Benign tumors do not penetrate adjacent tissue 
borders  and do  not spread or metastasize to  distant sites.  They also more closely 
resemble their tissue of origin.  In contrast, malignant tumors have the added property 
of  invading  surrounding  tissues  and  metastasizing  to  distant  sites,  where 
subpopulations of malignant cells  take  up  residence,  grow anew  and  invade again 
(Rubin,2001). 2 
1.1.2. CANADIAN AND QUEBEC CANCER STATISTICS 
Each  year  since  1987,  the  National  Cancer  Institute  of  Canada  (NCIC) 
publishes and interprets CUITent statistics about cancer in Canada. These statistics are 
compiled  through  a  collaboration  of  NCIC,  Health  Canada  Statistics,  Canada 
provincial/territorial cancer registries  and university-based research.  According ta 
these statistics, in  the year 2006, an  estimated 153  100 new cases of cancer will be 
diagnosed in Canada: 74700 in  women and 78 400 in men; and 38 300 new cases in 
Quebec: 19  100 women and 19 200 men.  There will be an estimated total of 70400 
cancer deaths  in  Canada  with  19  100  of them  attributed  ta  Quebec.  Across  the 
country, breast cancer remains  the leading cause of death for women  with  22  200 
new cases in  Canada and 6 000 in Quebec, and prostate cancer remains the leading 
cause  of cancer death  for  men  with  20  700  new  cases  in  Canada and  3  600  in 
Quebec.  Lung cancer remains the leading cause of cancer death, when women and 
men  are  considered  together,  with  colorectal  cancer following  in  a  close  second. 
According ta CUITent incidence rates, 38 percent of Canadian women and 44 percent 
of men  risk developing cancer during their lifetime.  Approximately 2 of every 5 
men and 1 in 2.6 women will develop cancer in their life, and 1 in 3.5 men and 1 in 
4.3 women, or approximately 1 in 4 of ail Canadians, will die of cancer.  The CUITent 
estimates for death due ta cancer according ta CUITent  mortality rates are 24 percent 
for  women  and  29  percent for  men.  There  are  40  percent of new  cases  and  60 
percent of deaths due ta cancer occuITing among those who are 70 years of age or 
aIder (Canadian Cancer Society www.cancer.ca).  These statistics clearly show the 
importance  of continuing  cancer  research  and  pushing  forward  ta  find  accurate 
methods of early diagnosis and effecti ve methods of treatment. 3 
1.1.3. CAUSES OF CANCER 
1.1.3.1. CHEMICAL CARCINOGENS 
The importance of chemicals as a cause of cancer has always been recognized 
and is  emphasized by  the  epidemic of tobacco-related  lung  cancer in  recent  years 
(Martinez et al.,  1995).  Chemical carcinogens are considered mutagens, since they 
are  agents  that  can  permanently  alter  the  genetic  material  of the  cell.  Chemicals 
cause  cancer  either  directly  or  after  metabolic  activation.  The  direct-acting 
carcmogens  are  inherently  sufficiently  reactive  to  bind  covalently  to  cellular 
macromolecules.  These  chemicals  include  organic  compounds  such  as  nitrogen 
mustard, benzyl chloride and certain metals like cadmium and nickel.  However, the 
great majority of organic compounds require conversion to an ultimate, more reactive 
compound.  This conversion is enzymatic and regulated by cellular systems involved 
in drug metabolism and detoxification, which are present in  many of the cells in  the 
body  and  particularly  in  liver cells  (Reddy,  1992).  Chemicals that  belong to  this 
group of carcinogens include aflatoxin, nitrosamines, aromatic amines and azo dyes, 
as  weil  as  sorne  compounds  found  in  tobacco  smoke,  like  polycyclic  aromatic 
hydrocarbons (Rubin, 2001).  Other than metabolism of carcinogens, sex, hormonal 
status and diet ail influence chemical carcinogenesis. 
1.1.3.2. PHYSICAL CARCINOGENS 
Physical agents of carcinogenesis include ionizing radiation, ultraviolet light 
(UV) and asbestos.  Ionizing radiation and ultraviolet radiation exhibit similar effects 
on cells, which include enzyme inactivation, inhibition of cell division, mutagenesis, 
cell death and tumorigenesis.  The importance of DNA repair in protecting against the 
harmful  effects  of  UV  radiation  can  be  seen  in  xeroderma  pigmentosum,  an 
autosomal recessive disease to which both neoplastic and non-neoplastic disorders of 
the  skin  are  attributed  to  impairment  in  excision  of UV  radiation-damaged  DNA 4 
(Rubi n,  2001).  Cancers  associated  with  exposure  to  asbestos  fi bers  through 
inhalation  are  mostly an  occupational  hazard of heavily exposed workers, either in 
asbestos  manufacturing,  mining,  installation  or demolition.  The  latent  period  for 
developing  an  asbestos  characteristic  tumor,  called  malignant  mesothelioma,  is 
anytime between  20 and 40 years  after exposure (Rubin,  2001).  Cancers can  also 
develop in  response to  a foreign  object implanted in  the  body such  as  a plastic or 
metal  film,  various fibers,  glass  spheres  and  dextran  polymers.  However,  humans 
appear to be resistant to foreign body carcinogenesis and few cancers arise following 
implants. 
1.1.3.3. VIRUSES 
The strongest association  between  viruses  and the development of cancer in 
humans are:  (1) the RNA  retrovirus Human T-Cell Leukemia Virus (HTLV-1) and 
human  T-cell  leukemia/lymphoma,  (2)  the  human  papillomavirus  (HPV)  and 
squamous carcinoma of the cervix (Munoz and Bosch, 1996), (3) the hepatitis Band 
C viruses (HBV/HCV) and primary hepatocellular carcinoma (BeasJey, 1988), (4) the 
Epstein-Barr  virus  (EBV)  and  certain  forms  of  lymphoma  and  nasopharyngeal 
carcinoma  (Magrath  and  Bathia,  1999),  and  (5)  human  herpesvirus  8  and  Kaposi 
sarcoma (Landau et al., 2001).  The HTLV-1 has been associated with the rare T-cell 
Jeukemias endemic in  parts of Japan, Africa, the Caribbean and southeastem United 
States.  HTLV-1  contains a genome with no known oncogene and does not integrate 
at specifie sites within the host genome.  It is  analogous to other retroviruses such as 
the human immunodeficiency viruses (HIV)-1 and -2.  The four DNA viruses, human 
papillomavirus (HPV), Epstein-Barr virus (EBV), hepatitis B (HBV), and herpesvirus 
8  contain  genes  that  encode  proteins,  which  bind  to  specifie  host  proteins,  the 
products of tumor suppressor genes, involved in  regulation of cell  proliferation and 
decouple  cell  proliferation  from  inhibitory  control.  The  transforrning  genes  of 5 
oncogenic  DNA  viroses  exhibit  almost  no  homology  with  cellular  genes  (Rubin, 
2001). 
1.1.3.4. GENETIC ALTERATIONS 
As  discussed earlier in  section 1.3.,  the  alterations  in  the  genetic  material  of 
the  cell  can  result  in  the  development  of cancer.  Mutations  in  oncogenes,  tumor 
suppressor genes and genes responsible for DNA repair throw off the delicate balance 
of  cell  proliferation  and  death.  Genetic  alterations  in  oncogenes  result  in 
overproduction of a normal gene product or synthesis of an  abnormally active mutant 
protein.  Another mechanism of a genetic alteration that contributes to carcinogenesis 
is a mutation that creates a deficiency in a normal  gene product that suppresses tumor 
formation;  such  is  the  case for  tumor suppressor gene  mutations.  Among  the  most 
extensively  studied  tumor suppressor genes  are  retinoblastoma  (Rb)  and  p53  gene 
products.  They serve  to  restrain  cell  division  in  many tissues  and  their absence or 
inactivation is  Iinked  to the development of tumors (Rubin, 2001).  Oncogenic DNA 
viroses encode products that interact with  these suppressor proteins, thus inactivating 
their function.  Genes involved in DNA repair respond to DNA damage and thus play 
a role in surveillance over the integrity of aIl genetic information.  Alterations, which 
with  time  may  lead  to  loss  of function  in  these  house-keeping  genes,  render DNA 
susceptible  to  the  progressive  accumulation  of other  mutations.  It is  impoltant  to 
consider  hereditary  syndromes  such  as  hereditary  non-polyposis  colon  cancer 
(HNPCC), which  displays  a heterozygous  germline mutation  in  at  least one of four 
genes involved in DNA mismatch repair.  Another hereditary syndrome to consider is 
ataxia telangiectasia (AT), which involves the ATM gene whose product participates 
in  multiple  responses  to  DNA  damage,  inc1uding  control  of checkpoints  in  the  cell 
cycle, activation of DNA repair enzymes, and regulation of apoptosis (Rubin, 2001; 
Stanley, 1995). 6 
1.1.3.5. TELOMERASE AND HUMAN CANCER 
As cells  divide,  their telomeres,  the  tips  of the  chromosomes, progressively 
shorten.  Because somatic cells do not normally express telomerase, an enzyme which 
maintains the length of the telomere, the  telomere progressively shortens with each 
replication,  thus  acting  as  a  molecular  clock  that  determines  the  lifespan  of  a 
replicating cell.  However, cancer cells express telomerase,  and reactivation of this 
enzyme is associated with immortalization of cancer cells (Rubin, 2001; Kim et al., 
1994). 
1.1.4. THE FIGHT AGAINST CANCER 
Cancer  treatment  varies  depending  on  the  nature  and  stage  of the  cancer, 
variables  pertaining to  the patient, as  weil  as  the goals of the  treatment.  The most 
common treatments of cancer include surgery, chemotherapy and radiation therapy. 
These may  be  employed alone  or in  combination.  Alternative  methods  in  cancer 
treatment  that  have  emerged  over  the  recent  years  include  immunotherapy,  gene 
therapy, enzymotherapy, herbaI  therapy and  hyperthermia.  A  novel  and promising 
new approach in cancer treatment is  the use of angiogenic agents which act to inhibit 
tumor blood vessel growth. 
1.1.4.1. SURGERY 
Surgery  is  the  oldest  form  of cancer  treatment.  It  remams  the  primary 
treatment for  a  variety of solid  tumors  such  as  breast,  colon, head  and  neck,  and 
uterine cancer.  It can be used to  diagnose or treat cancer.  Several types of surgical 
procedures exist depending on the stage and type of cancer.  Preventive surgery is 
performed  to  remove  non-malignant  tumor  masses  that  are  likely  to  become 
malignant, such as  polyps in the colon.  Diagnostic surgery is  used to obtain a tissue 7 
sample for  analysis  so  a biopsy  and  cancer staging can  be  done.  Curative surgery 
deals with the removal of a contained tumor mass.  However, there are other types of 
surgery  employed  in  cancer  treatment.  These  include:  cytoreductive,  palliative, 
supportive and reconstructive surgery (Fleming et al., 2001, Pollock et al., 2003). 
1.1.4.2. CHEMOTHERAPY 
Chemotherapy is  a systemic therapy,  which  affects the  whole body  by  going 
through  the  bloodstream  (Burke  et  al.,  1996).  The  purpose  of chemotherapy  and 
other systemic treatments is  to get rid of any cancer cells that may  have spread from 
the primary tumour.  Chemotherapy refers to  an  agent that attacks the cell directly, in 
an  attempt to  induce cell  death.  Chemotherapy is  used  to  eradicate cancer, maintain 
long-term remission,  to  increase  the  effectiveness of surgery or radiotherapy and  to 
help  control  pain  and  other symptoms  associated  with  the  particular cancer (Aiba, 
2004; Trotice et al.,  1997).  Chemotherapy is  an  area of treatment that is constantly 
changing  and  developing.  These  developments  include  new  anticancer  drugs,  new 
combinations of drugs, and "old"  combinations of drugs on  untested types  of cancer, 
as  weil  as  various  combination  treatments  involving  drugs  with  surgery  andJor 
radiation.  Chemotherapy  is  most  effective  against  cancers  that  divide  rapidly  and 
have  good  blood  supply.  Chemotherapy  may  be  given  as  a  single  drug  or  a 
combination  of  drugs.  Combinations  have  been  developed  for  several  reasons: 
different drugs attack the cancer cells in  different ways; sorne drugs may  make other 
drugs more potent; combinations help to avoid the problem of cancer cells becoming 
"immune" or resistant to  a certain drug; for many  kinds of cancer, a combination of 
drugs (each one of which is effective in  attacking that kind of cancer) provides more 
effective cancer-kill with fewer harmful effects on healthy tissues. 
Alkylating  agents  such  as  nitrogen  mustards  and  ethylamines  are  the  most 
commonly  used  in  chemotherapy.  Secondly,  plant (vinca) alkaloids are  anti-tumour 8 
agents  derived  from  plants.  The  best  known  of this  category  are  vincristine  and 
vinblastine  (Sui  and Fan, 2005).  Thirdly,  taxanes  are  groups of drugs  that  include 
paclitaxel and docetaxel (Bunn, 2000; Earhart, 1999), which are widely used to treat 
advanced ovarian and breast cancers (Khayat et al., 2000; Lamb and Wiseman, 1998). 
Finally, anti-metabolites, nitrosoureas and anti-tumour antibiotics are among the weil 
known categories of chemotherapeutic agents.  Anti-tumour antibiotics are a group of 
structurally unrelated antimicrobial compounds produced by streptomyces species in 
culture. They are cell cycle non-specifie. They are distinct from the antibiotics used to 
treat  bacterial  infections.  Rather,  these  drugs  affect  the  structure  and  function  of 
nucleic  acids  by  intercalation  between  base  pairs  and  by  causing  DNA  strand 
fragmentation  or  DNA  cross-linking.  However,  they  Jack  the  specificity  of  the 
antimicrobial  antibiotics  and  thus  produce  significant  toxicity.  A  number of anti­
tumour antibiotics such as  Adriamycin, dactinomycin,  bleomycin  and  mithramycin 
are used to treat a variety of cancers. 
1.1.4.3. RADIOTHERAPY 
Radiation  therapy  is  a  highJy  specifie  and  effective  modality  far  cancer 
treatment and  is  often  used after surgery.  Radiotherapy  is  usually  seen  as  a  direct 
attack on cells, similar to chemotherapy. It uses high energy radiation forms, such as 
X-rays, gamma, neutrons as weil  as  other sources to  kill cancer cells. Radiation has 
its greatest effect on tissues that divide rapidly.  The dose of radiation is  determined 
by the  size,  extent,  type  and  stage of tumour along  with  its  response  to  radiation 
therapy. CaJculations are performed to determine the dose and timing of radiation in 
treatment planning. Often, the treatment is gi ven over several different angles in arder 
to deliver the maximum amount of radiation to the tumour and the minimum amount 
to normal tissues (Perez and Brandy, 2002, Hof and Debus, 2005). 9 
1.2. APOPTOSIS 
1.2.1. OVERVIEW 
Apoptosis  refers  to  a  continuous  physiological  process  of  genetically 
programmed cell  death  defined  by distinct morphological  and  biochemical  changes. 
Regulation  of the  homeostatic  balance  between  cell  proliferation  and  cell  death  is 
essential  for  development  and  maintenance  of  multi-cellular  organisms.  The 
importance of apoptosis is  evident in  a wide variety of different biological  systems, 
including  normal  cell  turnover,  the  immune  system,  embryonic  development, 
metamorphosis, and  hormone dependent atrophy, as weil  as  in  chemical-induced cell 
death  (Arends  and  Wyllie,  1991;  Ellis  et  al.,  1991;  Cohen  et  al.,  1992).  The 
regulatory mechanisms controlling programmed cell death are  as fundamental, and as 
complex,  as  those  regulating cell  proliferation.  Changes  in  the  signalling cascades 
regulating apoptosis, whether by extra-cellular triggers, acquired or germ line genetic 
mutation, or viral  mimicry of signalling molecules, can result in  an  array of diseases, 
including  neurodegenerative diseases,  ischemic  damage,  autoimmune disorders  and 
several forms of cancer (Thompson,  1995; Nicholson,  1996).  Thus, the study of the 
mechanisms of apoptosis is one of the most active fields of medical research today. 
Apoptosis differs significantly from cell death by necrosis.  Death by necrosis 
occurs  due  to  a  failure  to  control  cellular  homeostasis  after  undergoing  damage 
(Schultz  and  Harrington,  2003).  Morphological  and  biochemical  characteristics  of 
necrosis  include:  swelling  of  the  cytoplasm  and  organelles  (particularly 
mitochondria),  organelle dissolution,  rupture of the  plasma  membranes  and  leakage 
of cellular contents  into  extra-cellular space.  Necrosis  typically  affects  groups  of 
contiguous  cells  and  an  inflammatory  reaction  usually  develops  in  adjacent  viable 
tissue  in  response  to  the  released  cellular debris.  Apoptosis  is  distinguished  from 
death by necrosis in  that it is  a closely regulated process induced by specific stimuli, 
including  cytokines,  hormones,  viruses  and  toxic  insults.  It occurs  without  the 
release of inflammatory mediators and affects mostly single cells or small groups of 10 
cells in an asynchronous fashion.  In  a morphological sense, it differs from necrosis in 
that  condensation  and  fragmentation  of  nuclear  chromatin  occurs,  as  weil  as 
compaction  of cytoplasmic  organelles,  dilatation  of the  endoplasmic  reticulum,  a 
decrease  in  cell  volume  and  alterations  to  the  plasma  membrane  resulting  in  the 
recognition  and  phagocytosis  of apoptotic  cells  (Figure  1.1)  (Arends  and  Wyllie, 
1991). 
The morphologieal changes which occur during apoptosis are accompanied by 
a number of biochemical changes.  Sorne of these changes occur at the cell  surface 
and promote recognition by  phagocytes (Homburg et al.,  1995; Martin et al.,  1995; 
Pradhan et al.,  1997; Savill, 1997).  Intracellular changes include the degradation of 
chromosomal DNA into high molecular weight (Canman et al.,  1992; Brown et al., 
1993;  Oberhammer  et  al.,  1993)  and  oligonucleosomal  fragments  (Wyllie  et  al., 
1980), as  well  as  cleavage of a specifie subset of cellular polypeptides (Kaufmann, 
1989;  Ucker et al.,  1992;  Lazebnik et al.,  1993).  This  cleavage  is  known  to  be 
accomplished  by  a  specialized  family  of  cystein-dependent  aspartate-directed 
proteases (Lazebnik et al., 1994) termed caspases (Alnemri et al., 1996). 
Two  major  apoptotic  pathways  exist:  the  extrinsic  pathway  (receptor­
mediated apoptosis)  and  the  intrinsic  pathway (mitochondria-associated  apoptosis). 
Both apoptotic signalling pathways converge at the level  of specifie proteases - the 
caspases. 11 
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Fig. 1.1 Morphologieal changes during apoptosis Apoptosis is defined by a distinct set of 
morphological changes  observed during cell death  including  loss of focal  adhesions.  Cells 
undergoing apoptosis usually exhibit a characteristic morphology, including fragmentation of 
the cell into  membrane-bound apoptotic bodies,  nuclear and  cytoplasmic condensation and 
endolytic  cIeavage  of the  DNA  into  small  oligonucleosomal  fragments.  The  cells  or 
fragments are then phagocyted by macrophages. 
(http://www.bendermedsystems.comll12.html). 
1.2.2  EXTRINSIC PATHWAY 
The extrinsic pathway involves the activation of  apoptotic signalling cascades 
by the binding of a specifie protein ligand to a cell  surface trans-membrane receptor 
(Figure 1.2) (Schultz and Harrington, 2003).  Death receptors involved in this process 
belong  to the  tumour  necrosis  factor  receptor  (TNF-R)  family  and  include  death 
receptors like Fas,  TNFRl, death receptor 3 (DR3),  TNF-related apoptosis-inducing 12 
ligand receptor 1 (TRAIL-Rl or DR4), TRAIL-R2 (DR5) and DR6.  These receptors 
are generally composed of 3 identical polypeptide chains and along with  individual 
characteristics also have binding and signalling features  in  common (Ashkenazi and 
Dixit, 1998; Rath and Aggerwal, 1999).  Each of the 6 DRs contains an  intracellular 
cytosolic death domain (DD), that functions as a protein-protein binding module after 
recruiting various cytosolic signalling molecules that comprise the specific apoptotic 
pathways (Schultz and Harrington, 2003). The receptor-induced pathway leads to the 
recruitment of procaspase-8 or -10 (initiator caspases) to the death inducing signalling 
complex  (DISC).  The  activated  caspase  is  capable  of directly  activating  effector 
caspases, such as caspase-3, -6 and -7. 
One of the  best characterized surface receptors  is  Fas  (Apo-l  or CD95),  a 
319-amino acid type 1 trans-membrane glycoprotein, with broad distribution on both 
lymphoid and non-lymphoid cells (Itoh et al.,  1991).  Fas is essential in  activation of 
apoptosis, as well as in the activation of the transcription factor nuclear factor (NF)­
KB  (Tartaglia et al.,  1993;  Lawen, 2003).  NF-KB  protects cells [rom apoptosis  by 
promoting  expression  of  survival  factors,  such  as  members  of  the  inhibitor  of 
apoptosis (JAP) family. An apoptotic signal results in target cells when FasR is bound 
by its natural ligand FasL or by agonistic antibodies.  FasL is expressed by activated 
CD4(+)  and  CD8(+) T  cells.  By  binding to  FasR expressed on  target cells,  these 
activated T cells can kill target cells. Fmthermore, it  is possible for ceJJs  to  activate 
their own Fas receptor in  an  autocrine fashion  and commit suicide (Wallach et al., 
1999).  The binding of FasL to  FasR leads to  receptor trimerization (Ashkenazi and 
Dixit,  1998;  Chinnaiyan  et  al.,  1996).  Adaptor  proteins  Iike  Fas-associated  death 
domain protein  (FADD) then  bind to the cytosolic death  domain  of FasR  via  their 
DDs.  FADD  also contains  a  second  protein-protein  interaction  domain,  the  death 
effector domain (DED) (Muzio et al.,  1996; Enari et al., 1998).  The DED of FADD 
binds to the DED or prodomain of caspase-8.  The complex of Fas, FasL, FADD and 
procaspase-8 is  caJJed the DISe.  The procaspase-8 molecules are brought into close 13 
proximity in  the DISC, thus they trans-activate each other.  Activated caspase-8 then 
activates downstream caspases such as caspase-3, -6, -7 and -9, resulting in apoptosis. 
However, there  are  other members of the TNF-R family that can signal for 
apoptosis  via  their DDs.  For instance,  tumour necrosis  factor-a (TNF-a)  interacts 
with  two  receptors,  TNFRI  (CD120a  or  p55)  and  TNFR2  (CD120b  or  p75)  to 
stimulate  multiple  biologie  responses  including  apoptosis  (Ashkenazi  and  Dixit, 
1998).  Although TNFRI has no DD, intracellularly, TNFRI associates with TNFR1­
associated  DD  (TRADD),  which,  via  its  DD,  binds  to  FADD,  and  results  In 
transmission  of  a  death  signal.  As  in  the  Fas  signalling  cascade,  activation  of 
caspase-8  via  the  recruitment  to  the  DISC  leads  to  the  cJeavage  of downstream 
caspases, such as caspase-3, an  endogenous endonucJease which targets the inhibitor 
of caspase-activated deoxyribonucJease (CAD) (Sakahira et al.,  1998).  The inhibitor 
of  CAD  (lCAD)  and  CAD  exist  as  an  inactive  complex.  ICAD  is  cleaved  by 
activated caspase-3 to release CAD, which can then enter the nucleus and degrade the 
cell's chromosomal DNA (Innler et al.,  1997),  leading to  DNA fragmentation  and 
ceU  death.  Death receptors (DR) 4  and 5 bind to  and are activated by TNF-related 
apoptosis-inducing ligand (TRAlL).  Through their cytosolic DD, they recruit FADD 
and form  a DISC as  described for Fas and TNFRI and  2.  DISC signalling can  be 
inhibited by the expression of the cellular Fas-associated DD-Iike interleukin (lL)-I­
converting  enzyme  inhibitory  protein  (c-FLIP).  c-FUP  is  a  dominant  negative 
caspase-8  that  leads  to  the  formation  of a  signalling inactive DISC (Thome et al., 
1997; Scaffidi et al., 1999; Tepper and Seldin, 1999; Scaffidi et al., 1998). 14 
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Fig.l.2. Proposed steps of apoptosis induced  by Fas  ligand:  Fas ligands, which 
usually exist as trimers, bind and activate their receptors by inducing receptor trimerization. 
Activated  receptors  recruit  adaptor  molecules  such  as  Fas-associating  protein  with  death 
domain (FADD),  which  recruit pro-easpase 8 to  the receptor complex, where it undergoes 
autocatalytic activation. Activated caspase 8 activates caspase 3 through two pathways; The 
complex one is that caspase 8 cleaves Bcl-2 interacting protein (Bid) and its COOH-terrninal 
part  translocates  to  mitochondria  where  it  triggers  cytochrome  c  release.  The  released 
cytochrome c binds to  apoptotic protease activating factor-l  (Apaf-l) together with  dATP 
and pro-easpase 9 and activates caspase 9. The caspase 9 cleaves pro-caspase 3 and activates 
caspase 3. The other pathway is that caspase 8 cleaves pro-caspase 3 directly and activates it 
(http://www.expertreviews.org). 15 
1.2.3.  INTRINSICPATHWAy 
The  intrinsic  apoptotic  pathway  is  associated  with  the  mitochondria.  It  is 
activated by a variety of extra- and intracellular stresses, including oxidative stress 
and cytotoxic drugs (Figure 1.3).  As  previously described for the extrinsic pathway, 
the TNF receptors, when bound to their appropriate ligand, can initiate a cascade of 
death signais.  One outcome of this is the activation of caspase-8 and in turn cleavage 
and  activation  of caspase-3.  In  the  presence  of caspase-3,  the  quantity  of active 
caspase-8 produced at the DISC determines whether a mitochondrial-dependent (Iow 
quantity, type II)  or -independent (high quantity, type l) apoptotic pathway is  used 
(Li et al.,  1998).  Caspase-8 also cleaves and acti vates a promoter of apoptosis in  the 
Bcl-2 family called Bid (Ghafourifar et al.,  1999),  which  becomes truncated (tBid) 
and translocates to the mitochondria resulting in the release of cytochrome c from the 
mitochondrial  inter-membrane  space  into  the  cytosol  (Figure  1.2).  Ceramide  is 
another factor that induces cytochrome c release from the mitochondria, generated by 
hydrolysis  of  sphingomyelin,  followed  by  activation  of  acidic  sphingomyelin 
(Waterhouse et al., 2002). 
Early  loss  of  mitochondrial  membrane  potential  and  the  opemng  of  the 
mitochondrial  permeability  pore  are  thought  to  be  necessary  for  the  release  of 
cytochrome c,  although  both events are not needed in  ail  instances (Ly et al.,  2003; 
van  Loo  et  al.,  2002).  A  range  of  other  apoptotic  molecules  in  addition  to 
cytochrome c is  released from the mitochondria (Figure 1.3) (Joza, 2001).  One such 
molecule  is  an  apoptosis-inducing  factor  (AIF),  which  has  been  shown  to  induce 
apoptosis  independently  of caspases  (Hunot and  FJavell,  2001;  Chai  et  al.,  2000). 
Another  molecule  that  is  released  is  second  mitochondria-derived  activator  of 
caspases (Smac)/DlABLO, which is  a protein that eliminates the inhibitory effect of 
lAPs and interferes with  their protective effect against ultraviolet radiation-induced 
cell  death  (Susin et al.,  1996).  After release from  the mitochondria, cytochrome c 
binds  to  the  apoptosis  protease-activating  factor  (Apaf)-I,  which  leads  to  the 16 
activation of caspase-9 and -3  and the release of Smac/DIABLO (Susin et al.,  1997; 
Li et al., 1997). 
Cytochrome  C  IS  a  required  cofactor  and  forms  a  complex  with  Apaf-l, 
procaspase-9 and deoxyadenosine monophosphate (dATP) (Kelekar and Thompson, 
1998).  This  large  complex  is  called  the  apoptosome  and  leads  to  activation  of 
caspases.  The apoptosome  consists  of seven  Apaf-l,  seven  cytochrome c,  seven 
dATP,  and seven  procaspase-9  molecules.  The apoptosome-bound procaspase-9  is 
auto-activated  and  goes  on  to  activate  effector caspases  such  as  caspase-3,  which 
leads  to  the  cleavage of a  number of cellular substrates  involved  in  apoptosis  and 
finally  endonuclease-dependent  fragmentation  of  the  cell's  DNA  (Schultz  and 
Harrington, 2003). 17 
Fig.1.3. Mitochondrial pathway of apoptosis. Mitochondria participate in apoptotic 
signalling  pathways  through  the  release  of mitochondrial  proteins  into  the  cytoplasm. 
Cytochrome c is  released from  mitochondria in  response to apoptotic signaIs, and activates 
Apaf-l, a protease released from mitochondria. Activated Apaf-l activates caspase-9 and the 
rest of the caspase pathway.  SmaclDIABLû is  released from  mitochondria and inhibits IAP 
proteins that normally interact with caspase-9 to  inhibit apoptosis.  Apoptosis  regulation  by 
Bc1-2 family proteins occurs as family members form complexes that enter the mitochondrial 
membrane,  regulating the  release of cytochrome c and  other proteins.  Apoptosis  inducing 
factor  (AIF)  is  another  mitochondrial  factor  that  is  released  into  the  cytoplasm to  induce 
apoptosis.  AIF-induced  apoptosis  is  important  during  development  but  is  not  caspase 
dependent (http://www.biocarta.com/pathfiles/h_mitochondriaPathway.asp). 18 
1.2.3.1.  BcI-2 FAMILY PROTEINS 
The release of apoptotic factors from the mitochondria is closely controlled by 
a group of proteins, which belong to  the Bel-2 family of proteins (Figure 1.3).  The 
Bel-2 family shares  homology within specifie regions, called Bel-2 homology (BH) 
domains, designated BH1, BH2, BH3  and BH4 (Adams and  Cory,  1998; Bomer et 
al.,  1994).  However, the overall amino acid sequence homology among members is 
low (Yin et al.,  1994; Farrow and Brown, 1996; Chittenden et al.,  1995; Wang et al., 
1996;  Huang et  al.,  1998;  McDonneli et  al.,  1999;  Korsmeyer,  1995;  Enari  et  al., 
1998).  Family  members  are  classified  based  on  function  and  BH-domain 
organization.  The proteins, via their BH domains, interact specifically to form either 
homo- or heterodimers, ultimately expressing their pro- or anti-apoptotic  influence. 
The family is  divided into three main groups: (1) the anti-apoptotic proteins, most of 
which contain a C-terminal membrane anchor and the four BH domains, like Bel-2, 
Bel-XL, Mcl-1, Al and Bel-w, (2) the pro-apoptotic members (which lack sorne of the 
four BH domains), like Bax, Bak, Bok and Bel-xs and (3) the BH3-only proteins (that 
only contain  the 3
rd  BH domain,  an  amphipathic  helical  structure,  and  are  ail  pro­
apoptotic), which  inelude Bik, Hrk,  Bim, Blk,  Bad and  Bid (Seshagiri  and Miller, 
1997).  The  relative  levels  of pro- and  anti-apoptotic  proteins  deterrnine  a  cell's 
susceptibility  to  apoptosis  (Chinnaiyan  et  al.,  1997).  Bel-2  family  members  also 
regulate caspase activation by altering the release of cytochrome c and changing the 
ability of scaffolding proteins such as  Apaf-1  to  recruit pro-caspase (Spector et  al., 
1997; Wu et al., 1997; Strasser et al., 2000). 
1.2.4.  CASPASES 
Both the extrinsic  and intrinsic  apoptotic  pathways converge at  the  level  of 
specifie  proteases - the  caspases.  There are  14  mammalian caspases  identified  to 
date  (Eamshaw et al.,  1999).  They are synthesized as  pro-enzymes,  which usually 19 
undergo proteolysis and activation  by  other caspases in  a cascade (Garcia-Calvo et 
al.,  1998).  Exceptions  to  this  are  procaspase-8  and  -9,  which  can  undergo 
autocleavage (Figure lA). They have a general organization in which the N-terminal 
prodomain is followed by a sequence encoding first a large and then a small subunit. 
In  sorne pro-caspase, these subunits are separated by  a small spacer that  is  excised 
from  the  pro-enzyme  during  its  maturation  (Garcia-Calvo  et  al.,  1998).  Peptide 
caspase  inhibitors  can  inhibit  downstream  caspase  activation  and  subsequently 
apoptosis  (Grutter, 2000).  Caspases are  divided  into  three groups:  (1)  the  initiator 
caspases  that  are  characterized  by  long  prodomains  (>90  ami no  acids)  containing 
either  death  effector  domains  (DED)  domains  (caspase-8  and  caspase-lO)  or  a 
caspase  recruitment  domain  (CARD)  (caspase-2  and  caspase-9;  CED-3);  (2)  the 
executioner or effector caspases containing short prodomains (caspase-3,  caspase-6 
and  caspase-7)  and  (3)  the  remaining  caspases  whose  main  role  lies  in  cytokine 
maturation rather than apoptosis (Walker et al.,  1994).  Each active caspase is derived 
from  processing  and  self-association  of  two  caspase  pro-enzymes  (Figure  104). 
During this conversion a  minimum of two c1eavages  take place, one separating the 
prodomain from  the large subunit and another separating the  large subunit from  the 
small subunits (Garcia-Calvo et al., 1998).  The resulting tetrameric enzymes contain 
two active sites at opposite ends of the molecule.  The large and small subunits within 
each  heterodimer  interdigitate  to  form  a  core  composed  of six-stranded  ~-sheets 
flanked  by  a-helices, a quaternary structure unique to  proteases (Mittl et al.,  1997; 
Rotonda et al., 1996; Wilson et al., 1994; Coleman et al., 2001). 20 
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Fig.1.4.  Structures of procaspase-8:  an  initiator  caspase,  and  procaspase-3,  an  effector 
caspase.  The heterotetrarneric enzyme shown on the right results from proteolytic activation, 
as described in the text (Garcia-Calvo et al.,  1998). 
Ali  caspases  hydrolyze  peptide bonds  on the  carboxyl  side  of an  aspartate 
residue  (Garcia-Calvo et  al.,  1998).  Initiator caspases  cleave and  activate effector 
caspases.  These then cleave cellular substrates, which leads to ail phenomena of the 
apoptotic  morphology.  The  unique  individual  structural  features  contribute  to  the 
different substrate specificities among caspases.  For instance one effector caspase, 
caspase-3, when activated, is capable of cleaving many important cellular substrates, 
including ICAD, Rho-associated coiled coil forming kinase 1 (ROCKl), poly (ADP­
ribose) polymerase (PARP, a DNA repair enzyme), actin,  fodrin and lamin involved 
in  maintaining cellular integrity.  Other caspase-3  substrates include protein kinases 
like  mitogen-activated  protein  kinase/extracellular  regulated  kinase  (MAPK/ERK) 
kinase  kinase  (MEKK-l),  p21-activated  kinase  (PAK2),  mammalian  Ste20-like 
kinases 1 and 2 (Mst1/Krs, Mst2), v-raf-l  murine leukemia viral oncogene homolog 1 
(Rafl) and other proteins involved in signal transduction pathways.  Active caspase-3 
can  cause  membrane  blebbing  via  ROCKI  cleavage,  which  leaves  the  kinase 
constitutively active, permanently phosphorylating myosin light chains (Sebbagh and 
Renvoize,  2001;  Leverrier  and  Ridley,  2001;  Nagata,  2000).  It  also  causes 21 
causes disassembly of the cell structure and DNA fragmentation via ICAD cleavage 
that,  as  previously described, sets CAD free  to  move into the nucleus (Birnbaum et 
al.,  1994). 
Caspase activation and activity can  be regulated by  interactions with several 
cellular proteins  (Figure  1.3).  One such  group  is  the  inhibitor of apoptosis  (JAP) 
protein group, which includes five polypeptides.  Four of these, the clAP-l, clAP-2, 
XIAP and NArp, each consist of an N-terrninal domain containing multiple copies of 
a baculovirus IAP repeat (BIR) motif (Lovering et al.,  1993) and aC-terminaI zinc­
containing  protein-protein  interaction  domain  (RING  finger)  (Liston  et  al.,  1996). 
The  fifth,  survivin,  contains  only  a  BIR  domain.  Each  of the  lAPs  can  inhibit 
apoptosis  induced  by  a  variety  of stimuli  (Duckett et  aL,  1996;  Ambrosini  et  aL, 
1997; Deveraux et al.,  1997).  XIAP, clAP-l, and clAP-2 bind to  and inhibit active 
caspase-3  and  -7  (Roy  et  al.,  1997;  Deveraux  et  al.,  1998).  They  also  bind  to 
procaspase-9 and prevent its activation (Salvesen and Duckett, 2002).  In addition to 
cellular  inhibitors  of apoptosis,  many  viruses  also  contain  viral  lAPs,  viral  anti­
apoptotic Bcl-2 proteins or other inhibitors of apoptosis in  order to  prevent infected 
host cells from dying (Moodie and Wolfrnan, 1994). 
1.2.5.  MITOGEN ACTIVATED PROTEIN KINASES 
As previously discussed, many cellular molecules are activated or deactivated 
during apoptosis.  One important group of cellular factors included in  this process is 
the  protein  kinases.  Three  parallel  mitogen  activated  protein  kinase  (MAPK) 
cascades  occur  in  mammalian  cells.  They  are  characterized  by  their  analogous 
effectors:  extracellular  signal-regulated  kinases  (Erk),  stress  activated  protein 
kinases/c-Jun-N-terminal (SAPK/Jnk), and p38
MAPK  (Figure 1.5).  The Erk pathway is 
triggered by a variety of growth factors, including serum.  Binding of the ligand to its 
G-protein  receptor  tyrosine  kinase  initiates  the  signalling  cascade,  which  is 22 
highlighted by the recruitment and activation of the Raf protein via Ras.  This triggers 
the  Erk pathway  (Marshall,  1994).  The activated  fOITIl  of Raf phosphorylates  the 
dual-specificity  kinases,  MAPKIERK  kinase  1  and  2  (MEK  1/2),  which  in  tum 
phosphorylate the Thr and Tyr residues of the Thr-G1u-Tyr (TEY) activation motif of 
ERK1/2.  The  phosphorylated  ERK1/2  translocates  to  the  nucleus,  where  it 
phosphorylates multiple substrates including activators of transcription Iike p90RSK 
S6  kinase  (Frodin  and  Gammeltoft,  1999),  MAPK-activated  protein  kinase 
(MAPKAK)-l,  phospholipase A2  and  mitogen- and  stress-activated  protein  kinase 
(MSK),  as  weil  as  transcription  factors  Elk-l,  Ats-1,  Sap1a,  rn-Mye,  signal 
transducers  and  activators  of transcription  proteins  (STAT)  such  as  Stat3,  adapter 
proteins  such  as  Sos,  growth  factor  receptors  such  as  the epidermal  growth  factor 
receptor (EGF),  and  estrogen receptors (Denhardt,  1996; Cahill,  1996).  Generally, 
activation  of the  ERK  signalling  pathway  has  a  role  in  mediating  cell  division, 
migration and survival. 
The SAPKJJnk pathway  is  stimulated by  stressors  like cytokines (TNP and 
FasL),  heat  shock,  oxidative  stress  and  UV  light  (Yan,  1994).  The  pathway  is 
understood  to  become  activated  through  the  phosphorylation  of the  MAPKIERK 
kinase kinase (MEKK) -l, a kinase analogous to the Raf protein in  the Erk pathway 
(Figure  1.5)  (Rirai  et al.,  1996).  At this  level  in  the cascade there  are  also  other 
MAPK kinase kinases (MKKKs), which include apoptosis-inducing kinase (ASK)  1 
and  a  member of the  mixed-lineage  kinases  (MLK) (Teramoto et al.,  1996).  The 
MKKKs are activated by GTP-binding proteins of the Rho family (Racs, Rhos, and 
the  Cdc42s)  (Yuasa et al.,  1998),  but may  occur independently of GTPases  (Yao, 
1997).  The MEKK-1 phosphorylates SAPKIERK kinase (SEK) -1  and MAPK kinase 
(MKK)  -7,  which  dually  activate  SAPK  via  phosphorylation  of the  Thr and  Tyr 
residues  of  the  Thr-Pro-Tyr  (TPY)  activation  motif (Shaulian  and  Karin,  2002). 
Similarly  to  Erk,  the  activated  SAPK  translocates  to  the  nucleus  where  it 
phosphorylates  c-Jun,  leading  to  increased  activity  of activator  protein-1  (AP-l) 23 
transcription factor (Atfi  et al., 1997).  Other transcription factors are also known  to 
be  targets including the nuclear activating transcription factor (ATF) -2, Elk-l, Myc, 
Smad3, tumour suppressor p53, nuclear factor of activated T-cells (NFAT) -4, DPC4, 
a human MAD related protein, and mitogen-activated kinase activating death domain 
protein (MADD), a cellular death domain protein (Zhang et al.,  1998; Hoeflich and 
Woodgett, 2001; Dougherty et  al.,  2002).  Activation of the  SAPKJJNK  signalling 
cascade generally results  in  apoptosis,  although  it  has  been  shown  to  promote cell 
survival under certain conditions, and is  involved in tumorigenesis and inflammation 
(Chaung, 2000). 
The p38
MAPK  pathway is activated by a variety of stressors and cellular insults 
such as  heat, oxidative stress, inflammatory cytokines and TNF receptor signalling, 
but not by mitogenic stimuli (Figure 5) (Rogalla et al.,  1999).  Although SAPK and 
p38
MAPK  pathways appear to share the same initiating O-protein, further investigation 
into the initial steps of this cascade is needed.  It has been found that MLK-3 activates 
MKK-3/6,  which  subsequently activates  the  p38
MAPK  route  by phosphorylating the 
Thr and Tyr residues of the Thr-Oly-Tyr (TOY) activation motif (Yan, 1994).  It has 
also  been  found  that  SEK-l  can  activate  p38
MAPK
,  thus  linking  it  to  the  SAPK 
pathway (Stein et al., 1997).  Once activated, p38
MAPK can phosphorylate and activate 
severa! transcription factors and modulate gene expression.  The p38
MAPK  is known to 
phosphory!ate  and  activate  the  ITÙtogen  activated  protein  kjnase-activated  protein 
kinase-213  (MK-2/3)  in  vivo,  which  then  phosphorylates  mammalian  heat  shock 
protein  HSP27  and  MAPK-activated protein-2  (MAPKAP-2)  (Farrow  and  Brown, 
1996).  In addition, p38MAPK can also activate ATF2, Sap-la (Kyriakis and Avruch, 
2001),  Stat,  MaxlMyc  complexes,  MEF-2A/C,  Elk-l  and  cyclic  AMP-responsive 
element binding protein  (CREB).  Thus, it  appears to  be important in  cell  motility, 
transcription and chromatin remodelling as weil as apoptosis (Cardone et al., 1997). 
The  protein  kinases  involved  in  apoptosis  are  highly  regulated  during  this 
process.  Many of them are cleaved in  or near their regulatory domains, producing 24 
catalytica11y competent fragments with increased activity.  These include the MEKKI 
(Deak et al.,  1998; Widmann et aL,  1998), p21-activated kinase (PAK) 2 (Rudel and 
Bockoch,  1997;  Lee  et  al.,  1997),  mammalian  Ste20-like  kinases  (Mstl/Krs  and 
Mst2) (Graves et al.,  1998; Lee et al.,  1998).  It has  been shown that in  certain cases 
the  expression  of  such  deregulated  kinases  in  cells  actively  promotes  apoptosjs 
(Graves et al., 1998; Xia et al., 1995).  Cleavage of three of these kinases may have a 
similar effect in  cells.  MEKK1, PAK2, and Mstl  are  ail  capable of activating the 
SAPKlJNK pathway (Deak et al.,  1998; Widmann et al.,  1998; Graves et al.,  1998; 
Lee et al.,  1998), which  leads  to heightened transcription of genes under control of 
the  transcription  factor  c-Jun.  These  three  kinases  ail  constitutively  activate 
SAPKlJNK, a kinase that is widely implicated in  apoptosis, whereas the antagonistic 
pathway (Earnshaw et al.,  1999) involving the classical MAP kinases ERK-l and -2, 
which  promote  ce11  survival,  is  extensively  disrupted  during  apoptosis  (Kuhl  and 
Rensing, 2000). 25
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Fig.1.5.  Overview  of  the  Mitogen-Activated  Protein  Kinase  (MAPK)  signalling 
pathways. The best described activators and downstream targets are shown.  The trans-acting 
factors  mediating effects of the ultimate kinases are not shown.  Mitogen-activated protein 
kinase  (MAPK)  pathways  (ERK,  JNK  and  p38)  are  a  farnily  of serine/threonine  protein 
kinase  that  have  been  shown  to  regulate  several  physiological  and  pathological  cellular 
phenomena, including inflammation, apoptotic cell death, oncogenic transformation, tumour 
cel! invasion and metastasis. The ERKl,2 pathway has been shown to stimulate cell growth 
and  oppose  the  apoptotic  effects  of JNKlSAPK  and  p38  pathways.  The  JNKs  and  p38 
signalling pathways are responsive to stress stimuli, such as cytokines, ultraviolet irradiation, 
heat shock, and osmotic shock, and are involved in cell differentiation and apoptosis. (Figure 
adapted from DM. Templeton) 26 
1.2.6.  HEAT SHOCK PROTEINS
 
Injured or stressed cells may undergo either necrosis or apoptosis, depending 
on the level of stress.  However, if the stress level  is very low, cells attempt to survi ve 
and  activate a stress response system.  Once the stress stimulus is  removed the  ceUs 
can  recover their normal  cellular function.  Briefly,  the effects of stress/heat shock 
response include:  1) inhibition of DNA synthesis, transcription, RNA processing and 
translation;  2)  inhibition  of progression  through  the  cell  cycle;  3)  denaturation  and 
misaggregation  of  proteins;  4)  increased  degradation  of  proteins  through  both 
proteasomal  and  Iysosomal  pathways;  5)  disruption  of cytoskeletal  components;  6) 
alterations in metabolism that lead to net reduction in cellular ATP; and 7) changes in 
membrane  permeability  that  lead  to  an  increase  in  intracellular  Na+,  H+  and  Ca
2+ 
(Lindquist,  1986; Sonna et aL,  2002; Jaattela,  1999).  In  mammalian ceUs,  non-Iethal 
heat  shock  produces  changes  in  gene  expression  and  in  the  activity  of expressed 
proteins  in  a stress/heat shock  response (Sonna  et  aL,  2002;  Parsell  and  Lindquist, 
1993).  This response characteristically includes an  increase in  thermo-tolerance, the 
ability to  survive subsequent, more severe heat stresses, as  weil  as  cross-tolerance to 
other stressors  (Creagh  et  aL,  2000).  These characteristics  of the  stress/heat shock 
response eamed it the weil  known name of the  chaperone system, which protects the 
cell  from  damage  and  in  extreme  stress  situations  leads  to  apoptosis  and  even 
necrosis (Ishikawa et aL,  1999). 
In  order to  understand  the important role  of heat  shock  proteins  (HSPs)  and 
their  relevance  to  apoptosis,  one  must  appreciate  their  function  in  the  stress/heat 
shock response in the cell.  HSPs are transcribed using the heat shock element (HSE), 
a stretch of DNA located in the promoter region of heat shock proteins (HSPs) and a 
number  of  other  genes  (Morimoto,  1998).  It  functions  as  a  binding  site  for 
transcription  factors  called  heat  shock  factors  (HSfs),  namely  HSf-l, HSf-2, and 
HSf-4 as  weil  as  HSPs  (Pirkkala  et  aL,  2001).  HSf-1  is  involved  in  the  acute 
response  to  heat  shock,  while  the  other  two  participate  in  a  number  of different 27 
regulatory  and  developmental  processes  (Pirkkala et al.,  2001;  Sarge et al.,  1993). 
Prior  to  heat  induced  activation,  HSF-l  exists  as  a  monomer  localized  in  the 
cytoplasm.  Ir is  thought to  be bound to HSPs in unstressed ceJls and activated by the 
increase in  concentration of denatured proteins which  present exposed hydrophobie 
domains  to  which  HSPs  bind,  releasing  HSF-l  (Pirkkala  et  al.,  2001).  After 
activation  by  thermal  stress,  HSF-l  is  found  in  the  nucleus  in  trimeric  form, 
concentrated  in  granules  (Georgopoulos  and  Welch,  1993).  It  is  this  activated 
trimeric form of HSF-1 that binds to the HSE and is involved in  increased HSP gene 
transcription during heat stress (Georgopoulos and Welch, 1993). 
HSPs play an  important role in  stabilization of proteins by helping to prevent 
misaggregation of denatured proteins and assisting in their refolding back into native 
conformations (Creagh et al.,  2000; Otterbein and Choi, 2000).  They also regulate 
cellular redox state and protein turnover (Creagh et al., 2000; Sreedhar and Csermely, 
2004).  Although  the  intensity and  duration  of the  heat stimulus  needed  to  induce 
HSP expression  vary considerably from tissue to  tissue,  a typical  in  vitro  exposure 
involves heating mammalian cells to 42-4SOC  for 20-60 minutes and  then  revelting 
them to  normothermic temperatures (37°C).  Several studies have shown that during 
the  period  of hyperthermia  and  shortly  thereafter,  HSPs  become  the  predominant 
proteins synthesized by cells (Feige and Poila, 1994). 
1.2.6.1. HEAT SHOCK PROTEINS: ROLE IN APOPTOSIS 
Heat shock proteins can  inhibit or aid  the apoptotic  machinery through their 
chaperone functions by affecting protein assembly and folding, ubiquitin degradation 
pathways and protein translation.  Chaperone-independent regulation of apoptosis by 
heat shock proteins is also reported in  the case of the JNK and AIF proteins.  HSP 70, 
HSP 27  and  HSP 90 represent  the  three  main  groups  of HSPs,  which  have  been 
implicated  in  the process of apoptosis (Figure 1.6).  HSP 70 belongs to  the HSP 70 28 
family of proteins, which function mainly as chaperones, interacting transiently with 
many proteins in  an  ATP-dependent manner (Liossis et  aL,  1997).  It is  present at 
basal  levels in  the  unstressed cell, but following stress it  becomes strongly induced 
and is present in  the cytosol and nucleus (Chant et aL,  1995).  However, its exact role 
in  apoptosis is  difficult to  define as  many contradictory findings have been observed 
in  regards  to  its  apoptotic  and  anti-apoptotic  functions.  HSP  70-induced 
thermotolerance  has  been  observed  to  cause  leukaemic  T  cells  to  become  more 
susceptible  to  receptor-mediated  Fas  and  T-cell/cell  death-3  antigen  receptor 
(TCRlCD3)-induced  apoptosis  (Filippovich  et  aL,  1994).  Several  studies  have 
reported enhanced apoptosis when HSP 70 levels are increased in  various other cells 
(Murdoch, 1995; Furlini et aL,  1994; Liossis et aL,  1997; Gao et al., 2001) 
HSP 70 has  been shown  to  have  an  overall  inhibitory  role  in  stress  kinase 
pathways.  HSP 70 proteins bind and stabilize protein kinase C (PKC) and Akt, also 
known  as  protein  kinase  B  (PKB),  both  of which  have  anti-apoptotic  properties 
(Konishi et al.,  1997). HSP 27 also increases Akt activity by an  unknown mechanism 
(Mosser et al., 2000).  HSP 70 inhibits stress signal-induced cell death by suppressing 
JNK activation, which is an important factor in  stress induced apoptosis. HSP 70 also 
appears  to  participate in  a  Bid-dependent cell  death  pathway.  HSP 70 appears  to 
affect the Bid-dependent apoptotic pathway negatively by  inhibiting JNK activation 
by a mechanism that is  not fully  understood (Gabai et al.,  2000; Gabai  et al., 2002; 
Beere et al., 2000).  HSP 70 has  also been observed to  directly interact with Apaf-1 
and inhibit apoptosome formation (Saleh et al., 2000; Ravagnan et al., 2001) as  well 
as  to  directly bind to  AIF, inhibiting AIF-dependent apoptosis (Jaattela et al.,  1998). 
In  addition, HSP 70 overexpression can inhibit caspase-dependent events that occur 
much later in apoptosis, such as activation of cytosolic phospholipase A2 and changes 
in  nuclear  morphology.  HSP 70 could  also  protect  cells  from  overexpression  of 
caspase-3 (Sakahira and Nagata, 2002).  ICAD seems to  recognize an  intermediate 
folding  state  conferred  by  HSP70-HSP40,  suggesting  that  they  may  promote  the 29 
formation  of  the  CAD-ICAD  complex  during  protein  translation  (Chretien  and 
Landry, 1988). 30 
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Fig.  1.6.  Heat  shock  proteins  (HSPs)  in 
the  regulation  of  the  major  events  in 
apoptosis.  Members of 3 of the major HSP 
families (HSP 27, HSP 70 and HSP 90) are 
shown to be involved.  (A) Regulation of the 
extrinsic pathway by Hsps. Hsps regulate at 
multiple  points  within  the  signalling 
pathways  activated  by  ligation  of  a  cell 
surface  death  receptor  by  the  appropriate 
ligand.  These  include  the  maintenance  of 
prosurvival  signais  generated  via  TNF­
mediated  activation  of  NF-KB  and 
suppression  of  proapoptotic  signalling 
events, e.g., JNK  activity and Bid cleavage. 
Integration  of  the  extrinsic  and  intrinsic 
pathways  is  mediated  via  the  caspase-8­
mediated cleavage  and  activation of Bid  as 
well as activation of JNK, which can impact 
on  numerous  molecules  that  regulate 
mitochondrial integrity (shown in the shaded 
area).  (B)  Regulation  of  the  intrinsic 
pathway  by  Hsps.  Hsps  regulate  several 
aspects  of the  intrinsic  apoptotic  pathway. 
These include both direct mediators such as 
Bax  and  indirect  regulators  such as  Akt of 
Mitochondrial  membrane  permeabilization 
to  prevent  MüMP  as  weil  as  events 
downstream  of mitochondrial  disruption  to 
regulate  apoptosome  assembly.  Caspase­
independent cell death may also be  affected 
via  HSP-mediated  suppression  of  AlF 
activity  and  inhibition  of  lysosome 
permeabilization  and  cathepsin  release 
(Beere, 2005; Feige and Poila, 1994). 32 
The stress inducible expression of HSP 27, a member of a small HSP family, 
has a significant role in protection against apoptosis (Figure 1.6) (Mehlen et al.,  1995; 
Mehlen et al.,  1996).  HSP 27 appears to inhibit apoptosis mediated through Fas and 
other receptor-mediated pathways.  It has been shown to block apoptosis induced by 
Fas, staurosporine, monocytes,  hydrogen peroxide and anti-cancer drugs (Mehlen et 
al.,  1996; Garrido et al.,  1997; Samali and Cotter, 1996; Jaattela and Wissing, 1993; 
Richards  et  al.,  1996;  Arrigo,  1998).  Upon  ligation,  the  adaptor  protein  DAXX 
(death associated protein) is  reportedly recruited to Fas receptor C-terminus, which is 
followed  by eventual  JNK activation  (Mehlen  et al.,  1996).  HSP 27  may interact 
with DAXX to  prevent its translocation from  the nucleus to the cytosol.  HSP 27 is 
also  thought to  regulate apoptosis by maintaining the redox  equilibrium of the  cell 
(Takayama et al., 2003) and has been demonstrated to inhibit apoptosis by increasing 
the intracellular level of the antioxidant glutathione (GSH) (Takayama et al., 2003). 
In  oxidative stress-induced apoptosis, HSP 27  has  been shown to  play a protecti ve 
role.  The inhibition of HSP 27  phosphorylation discourages the formation  of high 
molecular  weight  complexes  of HSP  27  and  in  tum  decreases  its  protective  role 
(Bruey et al., 2000).  Furthermore, overexpression of HSP 27 increases the resistance 
of cells  to  various  apoptotic  stimuli  (Takayama et al.,  2003).  One  mechanism  by 
which  HSP  27  could  interfere  with  apoptosis  is  by  directly  binding  to  cytosolic 
cytochrome c and sequestering it from Apaf-1  (Bruey et al., 2000).  High molecular 
weight  complexes  of HSP  27  appear  competent  to  inhibit  apoptosome  formation 
(Lewis et al., 2000). 
Finally, HSP 90  has  also  been implicated in  evasion of apoptosis.  HSP 90 
plays a role in  modulating TNF-receptor signalling.  Upon ligation of TNFR-1, the 
receptor  interacting  protein  (RIF)  is  recruited  to  the  receptor  and  promotes  the 
activation  of  NF-KB  and  JNK.  HSP  90  interacts  with  RIP,  resulting  in  its 
stabilization  (Chen  et  al.,  2002).  Otherwise,  RIP  is  rapidly  degraded  and  causes 
decreased TNF-induced NF-KB  activity and increased cell  vulnerability (Sato et al., 33 
2000).  HSP  90  is  equally  important for  the  correct association  of the  I-lCB  kinase 
(IKK) complex  which  affects TNF-induced NF-KB  activity  (Basso et  al., 2002).  It 
has  been  reported to  directly interact with  Akt.  When  this interaction was prevented 
with HSP 90  inhibitors, Akt was  dephosphorylated and  destabilized, which increased 
the likelihood of apoptosis (Samali et al.,  1999; Xanthoudakis et al.,  1999). 
In addition to the three main HSP families, the involvement of HSP 40 and 60 
has  also  been  recognized for  their role  in  apoptosis.  HSP  60  has  been  reported  to 
play  a role  in  caspase-3 maturation (Gupta and  Knowlton, 2002; Ling,  1992).  Both 
have been shown to complex with the proapoptotic protein Bax (Ling and Thompson, 
1973,  Gotoh et  al.,  2004).  Under hypoxic  conditions,  this  complex dissociates  and 
Bax  translocates  to  the  mitochondria  and  participates  in  apoptosis.  However,  their 
exact role in apoptosis is not yet fully understood. 
1.2.6.2. HYPERTHERMIA: HEAT SHOCK AS A CANCER TREATMENT 
Hyperthermia (HT) is  a relatively recent clinical procedure in  which  body tissues are 
exposed  to  elevated  temperatures  (40-44°C).  This  procedure  induces  tumour  cell 
death  by  a  spectrum  of molecular,  metaboIic,  cellular  and  tumour  tissue  changes, 
including  conformational  changes  of  cellular  proteins,  stimulation  of  immune 
response, as  welI  as  alterations of tumour rnicroenvironment (Streffer,  1995; Song et 
aL,  1995; Vaupel  and  KelIer,  1995; Issels,  1999; Feyerabend et  al.,  1999).  Clinical 
hyperthermia  can  be  divided  into  three  categories:  local  hyperthermia  (including 
superficial  local  and  interstitial  local  hyperthermia)  (LHT),  regional  hyperthermia 
(RHT),  and  whole  body  hypertherrnia  (WBH)  (Falk  and  Issels,  2001).  The 
application of heat can be  induced by eJectromagneti.c field  technique, ultrasound, or 
perfusion methods. Local  hyperthermia refers  to  heat that  is  applied to  a very  smalI 
area,  such as a tumour. The area may be heated extemalIy with high-frequency waves 
aimed at  a tumour from  a device outside the body (single microwave or ultrasound). 34 
To  achieve  internai  heating,  one of several  types  of sterile  probes  may  be  used, 
including  thin,  heated  wires  or  hollow  tubes  filled  with  warm  water;  implanted 
microwave  antennae;  and  radiofrequency  electrodes.  In  regional  hyperthermia,  an 
organ or a limb is heated. Magnets and microwave antennae that produce high energy 
are placed over the region to be heated. In perfusion, the patient's blood is  removed, 
heated, and then pumped into the region that is  to be heated internally. Whole-body 
heating is  used to  treat metastatic cancer that has spread throughout the body. It can 
be  accomplished  using  warm-water  blankets,  hot  wax,  inductive coils,  or thermal 
chambers and refers to the procedure of raising a patients' body-core temperature to 
40°C for 3-6 hours (Hildebrandt et al. 2005). 
Although, HT alone does not achieve valuable clinical effects in terms of long 
lasting  tumour remission  (Liu  and Wilson,  1998), there is  an  increasing amount of 
preclinical  and clinical  data suggesting that HT could be beneficial as  a subsidiary 
treatment to chemotherapy or radiotherapy (Bates and Mackillop,  1986).  The major 
advantage of combining HT with chemotherapy is  to  potentate the cytotoxic effects 
of anticancer drugs  in  the targeted region  of tumour, without increasing toxicity  to 
surrounding tissues.  Consequently, this could lead to an increase in  therapeutic index 
and a decrease in  the side effects caused by drugs (Streffer,  1995; Feyerabend et al., 
1999; Liu and Wilson, 1998; van  der Zee, 2002).  There are at least 18  randomized 
studies  which  have  demonstrated  that  the  combination  of HT  with  radiotherapy, 
chemotherapy or both, led to improved clinical outcome [Dahl, 1994; Dewhirst et al., 
2005].  This  was  demonstrated  for  tumours  of the  head  and  neck,  brain,  rectum, 
cervix, breast, lung, oesophagus, vulva/vagina and for melanoma (Jones et al., 2005). 
Hyperthermia  has  been  shown  to  increase  the  cytotoxic  effect  of  many 
anticancer drugs such as Adriamycin, bleomycin, BCNU, cisplatin, and the alkylating 
agent melphalan, from both in  vitro and in vivo studies (Li, 1984; Bates et al.,  1987; 
Orlandi et aL,  1995; Bates and Mackillop,  1990; Honess and Bleehen,  1988; Hahn, 
1979; Wallach, 1977).  This could be partly explained by membrane damage (Bates et 35 
al.,  1985)  or  by  altered  membrane  permeability  (Towle,  1994)  caused  by  heat, 
therefore allowing larger quantities of drugs to enter the cell.  It has been previously 
shown in  our lab that multidrug resistant (MOR) cells overexpressing P-glycoprotein 
(P-GP) did  not exhibit cross  resistance to  heat  suggesting that  heat shock could be 
useful  in  elimination of MOR cells.  Moreover, HT has  been observed to overcome 
primary resistance to drugs such as cisplatin, methotrexate and mitomycin c (Larrivee 
and AveriIl, 1999).  It has been documented that MOR due to overexpression of P-GP 
can  be  reversed  in  vitro  by  combining  HT  with  the  anticancer  drug  melphalan 
(Honess  and Bleehen,  1988).  Hyperthermia was  more effective in  reversing MOR 
involving P-GP when melphalan or Adriamycin was combined with P-GP modulators 
such  as  cyclosporin  A  (Larrivee  and  AveriIl,  2000;  Averill  and  Larrivee,  1998; 
Averill  and Su,  1999), verapamil  (Averill-Bates  and Courtemanche,  1995; Turcotte 
and  Averill-Bates,  2001),  or  with  the  glutathione  S-transferase  (GST)  inhibitor 
ethacrynic  acid  (Dumontet  et  al.,  1998).  The P-GP  modulator PSC  833  reduced 
resistance to vinblastine in MOR K562 and :MESSA cells at 43°C (IARC, 1989). 
1.2.7.  MULTIDRUG RESISTANCE 
Resistance  to  anti-neoplastic  agents  constitutes  a  major  obstacle  in  the 
treatment of many types of cancer.  The development of resistance to  one particular 
drug often confers  cross-resistance to  a wide range  of structurally and functionally 
unrelated  drugs  (Fajo  et  aL,  1985).  The  underlying  mechanisms  of  multidrug 
resistance  (MDR)  are  not  weIl  understood.  However,  the  phenotype  has  been 
associated  with  overexpression  of a  170  kDa  ATP-dependent  membrane  transport 
protein, P-glycoprotein (P-GP) (Skovsgaard, 1978; Kertner et al.,  1983; Krishna and 
Mayer, 2000).  P-GP is  part of the ATP-binding cassette (ABC) family of membrane 
transport ATPases,  which  are  of considerable clinical  importance.  In  general,  the 
transport  ATPases  are  comprised  of  four  structural  domains,  two  that  span  the 
membrane, each containing several transmembrane segments, and two that remain in 36 
the cytoplasm.  The last two units, termed the nucleotide binding domains, play a role 
in cleaving ATP to derive energy necessary for transporting cell nutrients (Figure 1.7) 
(Borst et al., 2000).  P-GP pumps substrates out of tumour cells through an  energy­
dependent mechanism in  a unidirectional fashion.  Therefore, it reduces intracellular 
drug concentrations and in tum decreases the cytotoxicity of anti-tumour drugs which 
include  anthracyclines,  vinca  alkaloids,  podophyllotoxins  and  taxanes.  P-GP  is 
present in  healthy human, mouse and hamster cells (Roninson et al.,  1986; Van der 
Bliek et al., 1987; Croop et al., 1989; de Bruijn et al.,  1986; Gros et al.,  1988).  It has 
also  been detected in  human  leukemias,  lymphomas, sarcomas and  neuroblastomas 
(Borst et al., 2000). 37 
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Fig.l.7. Structure of P-glycoprotein.  The transport ATPase is  comprised  of 4 structural 
units, two ofthem span the membrane, each containing several transmembrane segments, and 
two remain in the cytoplasm and play a  role in  cleaving ATP 10 derive energy needed for 
transporting cell nutrients. (Courtesy ohvww. chembio.uoguelph.calsharom!PgptopoI2.jpg) 
Another member of the ABC  family,  which has  been implicated in MDR of 
cancer cells is the multidrug resistance associated protein (MRP).  MRP is a 190 kDa 
membrane protein and  has  been described as a GS-X pump capable of transporting 
organic  anion  drug  conjugates  and  intact  anticancer  drugs  (Cole  et  al.,  1992; 
Krishnarnachary and  Center,  1993; Barrand et al.,  1994; Grant et al.,  1994; Borst et 
al.,  1997). MRP substrates include anthracyclines such as doxorubicin (DOX), vinca 
alkaloids and etoposide.  Although MRP is very similar to P-GP in terms of substrate 38 
specificity  and  action,  only  15%  amInO  acid  homology  exists  between  the  two 
proteins.  Several homologs of MRP have been identified, namely MRP-1 and MRP­
2 (cannalicular multispecific organic anion transporter or cMOAT) as weIl  as MRP3­
7  (Dahl,  1995).  The  c1inical  cancers  exhibiting  MRP  expression  include 
hematological, lung, acute Iymphoblastic leukemia and chronic leukemia (Borst et al., 
2000).  However, MRP is  also expressed in  normal  human tissue,  such as  muscle, 
lung, spleen, bladder, adrenal gland and gall bladder.  Reduced glutathione (OSH) has 
been  suggested  as  an  important  component  of  MRP-mediated  NIDR  and  drug 
transport (Borst et aL, 2000). 
Moreover, there are non-transport based mechanisms that affect multiple drug 
classes.  These  types  of resistance  can  be  caused  by  altered  activity  of specific 
enzyme systems such as  glutathione S-transferase (OST) and topoisomerase, which 
can decrease the cytotoxic effect of chemotherapeutic drugs in a manner independent 
of intracellular drug concentrations.  OST is  an  enzyme system involved in drug and 
xenobiotic  detoxification.  It  is  extensively  involved  in  the  metabolic  biotrans­
formation of many anti-cancer drugs.  Among these are nitrogen  mustards, such as 
BCNU  and  cyclophosphamides.  Several  resistant  cell  lines  have  been  shown  to 
overexpress OST (Borst et aL, 2000).  Further, the cellular regulation of OSH has also 
been  shown  to  play  a  key  role  in  detoxification  and  cellular  repair following  the 
damaging effects of DOX and alkylating agents.  Increases in  OSH levels have been 
observed  in  many  alkylating  agent-resistant  cell  lines  (Borst  et  aL,  2000).  This 
suggests that reduced levels of intracellular OSH will result in  chemosensitization of 
drug resistant cells.  Reduction of OSH with buthionine sulfoxime (BSO) has  been 
successfully  used  in  the  c1inic  to  sensitize  tumour  cells  to  treatments  with 
chemotherapy and radiotherapy (Bates et aL,  1995; Britten et aL, 1992). 
As mentioned earlier topoisomerase activity can also be involved in the MDR 
phenotype.  Two  types  of  topoisomerase  exist  in  eukaryotic  cells.  Type  1 
topoisomerase serves to alter DNA topology via single strand breaks, while type II 39 
topoisomerase alters DNA topology by causing transient double strand breaks.  Both 
enzyme  classes  are  involved  in  DNA  replication.  Consequently,  these  enzymes 
constitute therapeutic  targets  for  anti-cancer drugs  in  rapidly dividing tumour cells 
(Borst et al.,  2000).  Cells have been shown to  become resistant to  topoisomerase II 
inhibitors  such  as  DOX  and  etoposide  due  either  to  the  underexpression  of 
topoisomerase II or topoisomerase II gene mutations. Resistance may occur alone or 
along with P-GP overexpression. A compensatory overexpression of topoisomerase l 
has been observed in  cells resistant to  topoisomerase II  inhibitors, where cells have 
reduced topoisomerase II expression (Borst et al., 2000). 
In  addition, changes in  the balance of proteins that control apoptosis can also 
reduce  chemosensitivity  since  most  anticancer  drugs  are  believed  to  exert  their 
cytotoxic effects via apoptotic pathways.  Thus, resistance may develop with loss of 
genes required for cell  death such as  p53 or overexpression of genes that block cell 
death  such  as  proto-oncogenes  Iike  c-myc or c-fos (Solary et al.,  2001). Therefore, 
several  different approaches should be considered in  order to  effectively overcome 
MDR.  A promising new approach is  the implementation of hyperthermia discussed 
earlier. CHAPTER 2:  OBJECTIVES AND HYPOTHESIS
 
It has been suggested that MDR cells, aside from  resistance to chemotherapy, 
might  also  inhibit  apoptosis  at  a  variety  of  levels  within  the  death  signalling 
pathways.  Therefore,  reversai  of  MDR  or  sensitization  of  the  MDR  cells  to 
chemotherapeutic  drugs  as  weil  as  the  induction  of  apoptosis  in  MDR  cells  are 
essential parts of the search for successful treatments of cancer.  Thus, there are three 
major objectives to this study. 
1.  The first objective is to compare basal levels of pro- and anti-apoptotic 
proteins  in  multidrug-resistant  Chinese  hamster  ovary  cells  (CHRCS),  which 
overexpress  P-GP  in  comparison  to  their  respective  parental  drug-sensitive 
counterparts AuxB 1 cells. 
2.  The second  objecti ve  is  to  investigate  the  induction  of apoptosis  via 
the receptor-mediated pathway of apoptosis in  CHRCS  in comparison to AuxB 1 cells 
using hyperthermia to sensitize the cells. 
3.  The third objective is  to  investigate the  degree of involvement of the 
mitochondria-mediated  pathway  of apoptosis  in  response  to  heat  shock  in  CHRCS 
versus AuxB 1 cells. 
The model of multidrug resistance used in this study utilizes Chinese hamster 
ovary  cells  (CHRCS),  which  overexpress  P-GP  on  their  cellular  membrane.  It  is 
important  to  note  that  these  cells  confer resistance  to  chemotherapeutic  drugs  Iike 
colchicines,  Adriamycin  and  melphalan.  Before beginning to  investigate molecular 
mechanisms  of heat  shock  induced  apoptosis  in  CHRCS  and  their  parental  drug­
sensitive counterparts, AuxBl cells, it is crucial to establish whether these cells differ 
in  their basal  levels of pro- (Apaf-l, Bax, cytochrome c,  FADD) and  anti-apoptotic 41 
proteins (c-FUP) as  weil as  other proteins involved in  the apoptotic pathways, such 
as  caspases,  Fas  receptor,  ICAD  and  PARP.  Our  hypothesis  is  that  there  are 
differences between the CHRCS  and AuxB1 cells in  the basal  level of these proteins, 
which could render CHRCS cells resistant to apoptotic stimuli. 
In  order to  investigate the  mechanisms of heat-induced apoptosis  in  CHReS 
and AuxB1  cells, it is  important to  explore both the extrinsic and intrinsic apoptotic 
pathways.  A  variety  of markers  must  be  evaluated  to  assess  any  differences  in 
apoptotic signalling pathways between the two celllines.  To begin, the most general 
markers of apoptosis include nuclear chromatin condensation, caspase activation and 
the fate of caspase substrates such as ICAD and PARP.  Looking at the state of these 
proteins will  show whether caspase-dependent pathways are involved.  Further, the 
receptor-mediated  apoptotic  pathway  markers  include  the  expression  of  the  Fas 
receptor  on  the  membranes  of both  cell  lines  as  weil  as  the  expression  of anti­
apoptotic  proteins  like FUP and  IAP.  Previous studies  have  found  that  levels  of 
FLIP  are  down  regulated  after  exposing  Jurkat  and  HeLa  cells  to  hyperthermia 
(Notarbartolo et al., 2004), which is  thought to sensitize these cells to Fas-mediated 
apoptosis.  Meanwhile,  overexpression  of  lAPs  has  been  reported  in  NIDR  cells 
suggesting  a  possible route  of inhibition of apoptosis  in  MDR cells  (Ruefli  et al., 
2002).  When investigating receptor-mediated apoptotic pathways one must look at 
the involvement of the DISC components such as the translocation of FADD to the 
cell  membrane,  the cleavage of procaspase-8  as  weil  as  the  presence of the DISe 
complex itself as  a whole.  P-GP has  been found  to  inhibit caspase-8 activation but 
not formation of the DISC during Fas-induced apoptosis in  P-GP expressing tumour 
cells (Till et al., 1973). 
It  is  also imperative to explore the involvement of the mitochondria in  heat­
induced  apoptosis  in  the  two  cell  \ines.  The  assessment  of  the  mitochondrial 
membrane  potential  and  the  release  of cytochrome  cinto the  cytosol  would  be 
necessary.  The formation  and  presence of the  apoptosome  is  a  crucial  apoptotic 42 
event,  thus  the  presence  of  Apaf-l  and  cleavage  of  procaspase-9  should  be 
investigated.  We  expect  to  find  differences  in  the  receptor- and  mitochondria­
mediated  pathways  of apoptosis  between  the  multidrug-resistant  Chinese  hamster 
ovary ceUs  (CH
RC5) and their respective parental drug-sensitive counterparts AuxBl 
cells. CHAPTER 3:  EXPERIMENTAL RESULTS 
3.1.  Preface 
This chapter includes a manuscript presenting the results of the research project.  This 
manuscript will  be submitted in the near future to  the scientific journal Experimental 
Cell Research.  The article entitled "Molecular mechanisms of apoptosis activation by 
heat shock in multidrug-resistant Chinese hamster ovary cells" investigates the raie of 
receptor- and  mitochondria-mediated  apoptotic  pathways  induced  by  heat  shock  in 
multidrug-resistant  Chinese  hamster  ovary  cells  (CH
RC5)  and  their  parental 
counterparts, drug-sensitive AuxBl  cells.  The experiments and  the  composition of 
this  manuscript  were  done  by  Paulina  Wrzal  under  the  supervision  of Dr.  Diana 
Averil!. 3.2.  Manuscript 
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ABSTRACT 
Multidrug  resistance  (NIDR)  is  a  major  obstacle  limiting  the  use  of 
chemotherapy  in  cancer  treatment.  The MDR  phenotype  has  been  associated  with 
overexpression of P-glycoprotein. MDR cells, aside from resistance to chemotherapy, 
might  also  inhibit  apoptosis  at  a  variety  of  levels  within  the  death  signalling 
pathways.  Thus,  reversai  of  resistance  or  sensitization  of  the  MDR  cells  to 
chemotherapeutic  drugs  as  weil  as  the  induction  of  apoptosis  in  MDR  cells  are 
essential  parts  of the  search  for  more  successful  treatments  of cancer.  This  study 
investigates the  induction of apoptosis  in  NIDR  CH
RC5  cells in  comparison to  their 
parental,  drug sensitive AuxBl  Chinese hamster ovary cells, using  heat  shock.  We 
assessed  the  responses  of  MDR  and  drug  sensitive  cells  to  death  receptor  and 
mitochondria  mediated  signalling  pathways  of  apoptosis  in  order  to  investigate 
possible  mechanisms  of resistance  to  heat  shock  induced  cell  death.  Our findings 
show that in  the heat shock induced receptor mediated pathway of apoptosis CH
RC5 
cells  exhibit  higher  levels  of  cytosolic  FADD  and  lower  Jevels  of  caspase-8 
activation.  In  the  mitochondria mediated pathway of heat induced apoptosis CH
RC5 
cells  show  higher  levels  of  mitochondlial  Bax  and  higher  initial  mitochondrial 
membrane depolarization.  AIso, similar levels of cleavage of downstream substrates 
of caspase-3 were observed in the two celllines suggesting that overall, MDR CH
RC5 
ceIls  are  not  resistant  to  heat  shock induced  apoptosis,  compared  to  drug  sensitive 
cells.  This study reveaJs, for  the first time, the  major molecular mechanisms of heat 
shock  induced  apoptosis  in  MDR  tumor.  The  results  imply  that  hyperthermia  is  a 
promising method used ta irradicate MDR tumor cells in the clinic. 46 
INTRODUCTION 
Multidrug resistance  (MDR)  represents  a  major setback limiting  the  use of 
chemotherapy in cancer treatment.  The overexpression of a 170 kDa ATP-dependent 
membrane  transport  protein,  P-glycoprotein  (P-GP)  represents  one  of  the  main 
mechanisms associated with  the MDR phenotype (Juranka et al.  19S9; Ling,  1997; 
Yakirevich et al., 2006). P-GP functions as an efflux pump, carrying substrates out of 
tumor cells, resulting in decreased intracellular drug levels.  It has been suggested that 
NIDR  cells,  aside from  resistance to  cytotoxic effects of chemotherapy,  might also 
hinder apoptosis induced by drugs and other stressors at a variety of levels within the 
death signaling pathways (Dudley and  Lamming, 1996; Aouali et al., 2003). 
Apoptosis is  a mode of regulated cell death, which can be induced mainly by 
three  unique  signaling  pathways:  the  death  receptor-,  the  mitochondria- and  more 
recently,  the  endoplasmic  reticulum  (ER)-mediated  signaling pathways.  The death 
receptor-mediated  (extrinsic)  pathway  of  apoptosis  is  triggered  by  extracellular 
activation of death receptors such  as  Fas and tumor necrosis factor (TNF).  This is 
followed by the recruitment of adaptor proteins such as  Fas-associated death domain 
(FADD)  to  the  receptor and  subsequent binding of procaspase-S  and  activation  of 
caspase-S (Salvesen and Dixit,  1999; Kim, 2002).  The activated initiator caspase-S 
then  goes on  to cleave and activate other substrates such  as  effector caspase-3 and 
pro-apoptotic  Bcl-2  family  protein  Bid  (Bamhart  et  al.,  2003).  Once  activated, 
effector  caspase-3  cleaves  many  of  its  substrates  such  as  inhibitor  of  caspases 
activated DNase (lCAD) and  poly (ADP-ribose) polymerase (PARP) (Nagata et al., 
2000).  These  downstream  effects,  which  include  chromatin  condensation  and 
fragmentation  and  the  formation  of apoptotic  bodies,  lead  to  the  phenomenon  of 
apoptosis.  Two other initiators,  caspase-lO  and  -2  are  similarly activated  via  cell 
surface receptors but through the TNRFI and death receptor 5 (DR5) receptors.  Like 
caspase-S, they cleave their substrates such as Bid and caspases-3 and -9, propelling 
cell death (Eamshaw et al., 1999). 47 
On  the  other  hand,  mitochondria-mediated  apoptosis  can  be  triggered  by 
chemotherapeutic drugs and a variety of environmental stresses.  These stimuli cause 
a shift  in  the  balance  between  pro- and  anti-apoptotic  Bcl-2 family  members.  For 
instance,  the  translocation  of pro-apoptotic  protein  Bax  from  the  cytoplasm  to  the 
mitochondrial  membrane,  where  it  participates  in  formation  of pores  in  the  outer 
mitochondrial  membrane,  leads  to  membrane depolarization  and  subsequent  release 
of other pro-apoptotic  proteins such  as  cytochrome cinto the cytosol  (Robertson et 
al.,  2003).  Once  in  the  cytosol,  cytochrome  c  associates  with  apoptosis  protease 
activating  factor  (Apaf-l)  and  the  initiator  procaspase-9,  forming  the  apoptosome. 
Under these circumstances, activation of caspase-9 is achieved followed by activation 
of effector caspases like caspase-3 and this eventually leads to  apoptosis (Ringger et 
aL,  2004).  The  two  main  apoptotic  signaling  pathways  communicate  via  a  pro­
apoptotic  protein  Bid  that,  once  cleaved  by  either  caspase-8  or  -10  into  tBid, 
translocates  from  the  cytosol  to  the  outer  mitochondrial  membrane  causing  its 
permeabilization and either initiating or magnifying mitochondria-mediated apoptosis 
(Gross, 2006). 
The  more  recently discovered ER  signaling pathway appears  to  be  mediated 
by  several  apoptotic  pathways  (Momoi,  2006).  These  include  activation  of  the 
initiator caspase-12, which  is  thought to  be  activated by  proteases such  as  caspase-7 
and  calcium-dependent  calpain.  The  apoptosis  signaling  kinase/c-Jun  N-terminal 
kinase  (ASK/JNK)  pathway  leads  to  Bax-dependent  cytochrome  c  release  from 
mitochondria  and  caspase-9  activation.  The  ER  membrane  protein  Bap31  and 
caspase-8 form  a complex,  which  leads  to  activation  of caspase-8, cleavage of Bid, 
cytochrome c release from mitochondria and caspase-9 activation. 
Heat shock or hyperthermia is currently being used in the cancer clinic in 
combination with radiation therapy and/or chemotherapy. The aim is to sensitize 
tumor cells and render them more responsive to these cytotoxic treatments without 
increasing toxicity to normal tissues, resulting in a higher therapeutic index (Dahl, 48 
1995; Issels, 1999; Feyeraband et al., 1999; Van de Zee, 2002). Several recent studies 
have reported improvement of tumor response to radiation and chemotherapy in 
combination with heat shock in the clinic for tumors of the head and neck, brain, 
rectum, cervix, breast, lung, esophagus, vulva/vagina, and for melanoma (Jones et al., 
2005; De Wit et al., 1999; Van der Zee et al., 2000; Issels et al., 2001; Wendtner et 
al., 2001; Wust et al., 2002; Hindebrandt et al., 2004; Fraker, 2004). 
Furthermore,  several  in  vitro  studies  indicate that  heat  in  combination  with 
chemotherapy can  sensitize MDR tumor cells  and  render them  more responsive  to 
this  cytotoxic  cancer  treatment.  We  previously  demonstrated  that  MDR  cells 
overexpressing P-GP or MRPI  did  not exhibit cross-resistance to  heat (Bates  and 
Mackillop,  1986;  Souslova  and  Avelill-Bates,  2004).  These  cells  show  similar 
sensitivity to heat induced cytotoxicity as their drug-sensitive counterparts. However, 
hyperthermia either alone, or combined with chemosensitizers such as  cyclospoline 
A,  PSC833  and  verapamil,  was  able  to  reverse  P-GP-mediated  MDR  to 
chemotherapeutic agents  such as  Adliamycin,  melphalan,  vinblastine and docetaxel 
(Bates  and  Mackillop,  1990;  Averill  and  Larrivée,  1998;  Averill  and  Su,  1999; 
Larrivée  and  Avelill,  2000;  Dumontet et  al.,  1998,  Liu  et  al.,  2001).  Therefore, 
hyperthermia  appears  to  be  a  promising  means  for  eliminating  MDR  tumor cells 
and/or improving their sensitivity to  cytotoxic agents.  An  advantage is  that heat  is 
essentially  non-toxic  compared  to  the  toxicity  of  chemosensitizers  such  as 
cyclosporin A,  verapamil or PSC833, which limits their clinical use.  However, little 
is known about the mechanisms by which heat shocklhyperthermia causes cell death 
by apoptosis in MDR cells. 
This study investigates the molecular mechanisms of heat shock-induced cell 
death  by  apoptosis  in  Chinese  hamster  ovary  cells,  assessing  the  differences  in 
responses to  heat  shock that could occur between drug-sensitive  AuxB 1 and :MDR 
CH
RC5 cells overexpressing P-GP. A comprehensive look into possible differences 
that  may exist in  major apoptotic  signaling  pathways  will  provide  a  glimpse  into 49 
mechanisms that not only confer MDR in  these cells, but also help to  maintain MDR 
by  evading  cell  death  by  apoptosis.  These  findings  will  also  offer  ideas  on  the 
potential clinical use of heat shock to increase sensitivity of MDR cells to apoptosis. 50 
MATERIALS AND METHODS 
CELL CULTURE 
The MDR cell line CH
RC5 was selected for resistance to colchicine from the 
drug-sensitive AuxBl  parent cell  line (Ling and Thompson,  1973).  The resistance 
factor  to  colchicine  is  approximately  300-fold,  but  CH
RC5  cells  are  also  cross­
resistant  to  other  anticancer  drugs  including  Vinca  alkaloids,  Adriamycin  and 
melphalan (El1iott  and Ling,  1981).  The CHa cell  lines  AuxBl  and CH
RC5  were 
grown  in  monolayers  in  tissue culture flasks  at  37°C under 5% COz  in  minimum 
essential medium (MEM) Alpha, supplemented with  10% fetal  bovine serum (FBS) 
and 1% penicillin (50 U/ml)-streptomycin (5  ).!g/ml)  (Invitrogen Canada, Burlington, 
ON).  The culture medium for the cell  line CH
RC5 contained colchicine (5  ).!g/ml) 
(Sigma  Chemical  Co.,  St.  Louis,  MO),  which  was  removed for  the  final  passage 
before experiments.  Studies were carried out  using cells  grown  to  confluence and 
incubated for 24 h at 37°C with fresh culture medium prior to each experiment. Cells 
were  harvested  with  phosphate-buffered  saline  (PBS)  containing  sodium  citrate 
(0.015 M), washed by centrifugation, and resuspended in  PBS containing 1% bovine 
serum albumin (BSA) and 10 mM glucose (Turcotte and Averill-Bates, 2001). 
DETERMINATION OF CASPASE ACTIVITY 
Freshly  harvested  CH
RC5  and  AuxB 1  CHa  cells  (l  x  106/ml)  were 
resuspended in PBS-BSA 1%, 10 mM glucose and incubated in a final volume of 1.0 
ml at the appropriate temperature ranging between 37-43°C in  temperature-controlled 
water baths (Haake D8, Fisher Scientific, Montreal), with a temperature precision of 
±  0.02°C.  Under these  conditions,  5  ml  of cell  suspension  reached  a  temperature 
within 0.1Oc  of the  water bath  temperature within  5  min. The time for heat shock 
treatment was calculated after the 5  min  heating period.  After the appropriate time, 
the cells were washed once with cold PBS by centrifugation (lOOOg,  3  min) to stop 51 
the heat treatment.  The cells were resuspended in  75  I"tl  of reaction buffer (20  mM 
piperazine-N,N'-bis(2-ethanesulfonic  acid)  (PIPES),  100  mM  NaCl,  10  mM 
dithiothreitol (DIT), 1 mM EDTA, 0,,1 % 3-[(3 cholamidopropyl) dimethylammonio]­
2-hydroxy-l-propanesulfonic acid  (CHAPS),  10% sucrose,  pH 7,,2)  (Stennicke and 
Salvesen,  1997) and were deposited into 96-well plates and broken by freezing at  ­
20°C for 20 minutes"  The kinetic reaction was started after addition of 25  I"tl  of the 
appropriate  caspase  substrate  (50  !lM)  at  37°C  and  measured  using  a 
spectrofluorimeter  (Spectra  Max  Gemini,  Molecular  Devices,  Sunnyvale,  CA)" 
Caspase-3 activity was  measured by cleavage of the fluorogenic  substrate N-acetyl­
Asp-G1u-Val-Asp-amino-4-methylcoumarin  to  produce  amino  methylcoumarin 
(AMC) and caspase-6 activity was measured by cleavage of the substrate Ac-VEID­
AMC,  with  Àmax  excitation  at  380  nm  and  Àmax  emission  at  460  nm  for  both 
(Calbiochem,  La Jolla,  CA).  Caspase-7  activity  was  measured  by  cleavage of the 
fluorogenic  substrate MCA-VDQVDGWK(DNP)-NH2 with Àmax  excitation at  325 
nm and Àmax  emission at 395 nm.  Caspase-8 activity was  measured by cleavage of 
Z-IETD-AFC  to  produce amino trifluorocoumarin (AFC) and caspase-9 activity was 
measured by cleavage Ac-LEHD-AFC, with Àmax  excitation at 415  nm and Àmax 
emission  at  490  nm  for  both  (Bettaieb  and  Averill-Bates,  2005).  Activities  of 
caspases-2 and -10 were measured by cleavage of the substrates ZVDVAD-AFC and 
AEVD-AFC respectively, with Àmax excitation at 400 nm and Àmax emission at 505 
nm for both. Activities of caspases are represented as Vmax of the kinetic reaction. 
ANALYSIS OF PROTEIN EXPRESSION BY WESTERN BLOT 
1.  Relative  expression  of Procaspases,  FasR,  FADD,  c-Flip,  Bax,  Cytochrome  c, 
Apaf-1, Bid, lAPs, Survivin and HSPs in AuxB1 and CHRCS ceUs: 
To assess and compare total levels of protein expression for apoptotic proteins 
between NIDR CHRCS  and AuxB 1 cells, freshly harvested CHO cells (l0 x  10
6/ml) 52 
were resuspended in  PBS-BSA  1%,  lOmM glucose and then  centrifuged (1000g,  3 
min). Cells were then resuspended in  500 {LI  of lysis buffer H  (10 mM Tris, pH 7.4, 
100  mM NaCl,  1 mM EDTA,  1 mM EGTA,  1 mM NaF, 20 mM Na4P207,  2  mM 
Na3V04, 0.1%  sodium dodecyl  (lauryl)  sulfate  (SDS),  0.5%  sodium deoxycholate, 
1% Triton X-100, 10% glycerol,  1 mM phenylmethylsulphonylfluoride (PMSF) and 
100  {LillO  ml  of protease  inhibitor  cocktail)  (Sigma-Aldrich,  St.  Louis,  MO)  and 
incubated on ice (O°C)  for 2 h and mixed every 15  min.  Debris, unbroken cells and 
nuclei were removed by centrifugation (2500g for  10 min) and the supematant was 
collected.  Proteins  were  quantified  according  to  Bradford  (Bradford,  1976), 
solubilised  in  Laemmli  sample buffer and  then  boiled for  5  min  at  95°C.  Protein 
samples  (30  {Lg)  were  separated  by SDS-polyacrylamide gel  elecrophoresis (SDS­
PAGE) according to Laemmli (Laemmli, 1970). Electrophoresis was carried out at a 
constant voltage of 125  V.  Cellular proteins were transferred electrophoretically to  a 
polyvinylidene  difluoride  (PVDF)  membrane  using  a  MilliBlot  Graphite 
Electroblotter l  apparatus (Milli-pore, Bedford, MA). The transfer buffer contained 
96 mM glycine, 10 mM Tris and 10% methanol. The transfer was carried out for 1.5 
h at constant amperage of 80 mA/gel.  Hydrophobic or nonspecific sites were blocked 
either for 1 h at RT or ovemight at 4°C with 5% powdered skim milk in Tris-buffered 
saline  (50  mM  Tris  and  150  mM  NaCl)  containing  0.1 %  Tween  20  (TBS-T). 
Membranes were washed four times for 15  min in  TBS-T (Tanel and Averill-Bates, 
2005).  The blots  were  probed with  primary antibodies  (1: 1000):  anti-Fas Receptor 
(FasR), anti-c-Flip, anti-Bax, anti-c-IAP1I2 and anti-survivin (Santa Cruz, CA), anti­
Apaf-1 (Chemicon, Temicula, CA), anti-cytochrome c (BD Biosciences, Mississauga, 
ON),  anti-Bid,  anti-HSP90,  anti-HSP70,  anti-FADD  (1:4000)  (Stressgen,  Victoria, 
BC) and Hsp27 L2R3 (gift from Dr. Jacques Landry, Centre de recherche, Hotel-Dieu 
de Québec, QC, Canada).  Secondary antibodies consisted of horseradish peroxidase 
(HRP)-conjugated  goat  anti-mouse,  anti-rabbit  and  anti-goat  IgG  (Biosource, 
Camarillo, CA). The PVDF membranes were incubated with the primary antibody in 
TBS-T,  1%  BSA for  1 h at  room temperature. Membranes were washed four times 53 
for  15  mm  and  incubated  for  1  h  at  RT  with  peroxidase-conjugated  secondary 
antibody  (1: 1000)  in  TBS-T containing  5%  milk  powder.  PVDF membranes  were 
washed  four  times  for  15  min  and  proteins  were  detected  using  the  ECL  plus 
chemiluminescence kit (PerkinElmer, Boston, MA). For verification of equal  protein 
loading, the  blots were probed with anti-GAPDH (Santa Cruz, CA) antibody and  by 
coloration of the gels using Coomassie blue. Protein expression was quantified using 
a scanning laser densitometer, relative to GAPDH (Molecular Dynamics, Sunnyvale, 
CA). 
2.  Cleavage ofProcaspases. /CAD and PARP: 
Early (1  h) and late (2 h) apoptotic events were investigated by the assessment 
of cleavage of initiator caspase procaspase-8, as  weil  as caspase substrates ICAD and 
PARP.  Freshly harvested CH
RC5  and AuxB1  cells (10  x 10
6/ml) were  resuspended 
in  PBS-BSA  1%,  10  mM  glucose  and  incubated  in  a final  volume  of 5 ml  at  the 
appropriate  temperature  ranging  between  37-43  oC  in  temperature-controlled  water 
baths.  After  the  appropriate  time,  cells  were  washed  once  with  cold  PBS  by 
centrifugation (1000  g,  3 min)  to  stop  the  heat  treatment,  resuspended in  500  ,ul  of 
lysis buffer H and incubated on ice (0 OC) for 2 h, and mixed using quick vortex every 
15  min.  Debris, unbroken cells and  nuclei  were  removed  by  centrifugation (2500  g 
for  10  min)  and  the  supematant  was  collected.  Protein  samples  (30  ug)  were 
separated by SDS-PAGE and immunoblotted with primary antibodies (1:1000):  anti­
ICAD,  anti-PARP  and  anti-caspase-8  (Santa  Cruz,  CA),  and  appropriate secondary 
antibodies, as described above. 
3.  Translocation ofFADD. Bax.  tBid and Cytochrome c: 
In  order to investigate the translocation of apoptotic proteins between cellular 
compartments,  induced  by  heat  shock,  cellular  fractionation  was  performed  as 54 
described previously with modifications (Jurkiewicz and Averill-Bates, 2004; Samali 
et al.,  1999). Following heat shock treatment for 1 h at temperatures ranging between 
37-43°C, CH
RC5 and AuxB 1 cells (20 x  106/ml) were washed once with cold buffer 
A (100 mM sucrose, 1 mM EGTA, 20 mM MOPS, pH 7.4) and resuspended in  Iysis 
buffer B (100 mM sucrose, 1 mM EGTA, 20 mM MOPS, 0.1  mM (DIT), 5% freshly 
added percoll, 0.01 % digitonin, 1 mM PMSF and 100 ui/IO ml of cocktail of protease 
inhibitors,  pH  7.4).  Membranes  were  broken  using  a  dounce  homogeniser  (50 
strokes/sample). Debris, unbroken cells and  nuclei  were removed by  centrifugation 
(2500 g for 10  min) and supernatants were then centrifuged (15,000 g for 15  min) to 
separate mitochondria.  Supernatants  were collected and centrifuged (100,000 g  for 
1h)  to  separate the cytosolic fraction  from  the  nucleosomal  fraction.  Mitochondrial 
fractions  were  resuspended  in  lysis  buffer  H.  Protein  samples  (30  p..g)  for 
mitochondrial, cytosolic and/or microsomal fractions were separated by SDS-PAGE 
and  immunoblotted  with  primary  antibodies:  anti-FADD  (1:4000),  anti-Bax,  anti­
cytochrome c and anti-tBid (Stressgen, Victoria, BC) (1: 1000).  Purity of subcellular 
fractions was verified by GSTnl (Calbiochem, La Jolla, CA), cytochrome oxidase and 
calnexin  antibodies  (Molecular  Probes,  Eugene,  OR),  specifie  to  cytoplasmic, 
mitochondrial and microsomal fractions, respectively. 
DETERMINATION OF APOPTOSIS BY FLOW CYTOMETRY 
1.  Mitochondrial Membrane Potential (1/ffm): 
Following heating at different temperatures (37-43°C) for  1 h,  MDR CH
RC5 
and  AuxB1  cells  (lx106)  were incubated  with  the  lipophilic  cationic  dye  5,5,6,6'­
tetrachloro-1,1',3,3'tetra-ethyl-benzimidazolyl-carbocyanine-iodide  (JC-1)  (5  p..M) 
(Molecular Probes) for  30 min  at  37°C (Mancini et al.,  1997).  Cells were  washed 
three times by centrifugation (2,500g, 3 min) and resuspended in  1 ml  of cold PBS. 
Prior to analysis, 10 p..g/ml of propidium iodide (PI) was added to stain necrotic cells. 55 
Data were collected using a FACS scan f10w  cytometer equipped with an  argon laser 
emitting  at  488  nm  and  analyzed  using  Cell  Quest  software  (Becton-Dickjnson, 
Menlo  Park,  CA).  Forward and  side  scatters  were  used  to  establish  size  gates  and 
exclude cellular debris from  the  analysis.  JC-l emission was collected on  FL-l  and 
FL-2 channels  at  530  (± 20)  nm  and  590 (± 20)  nm,  respectively. The PI  emission 
was collected on  the FL-3 channel (620 ±  15  nm). Ten thousand cells were anal yzed 
for  each  sample.  Under  normal  conditions,  JC-l  exists  in  a  monomeric  form  and 
stains  as  green  fluorescence  (FL-l).  JC-l  forms  J-aggregates  in  the  presence  of 
increasing mHochondrial  potential. These J-aggregates give  a red  fluorescence  (FL­
2).  By comparing the green/red fluorescence ratio, after removing PI-stained necrotic 
cells, one can determine the changes in mitochondrial membrane potential  (~\lfm). 
2.  Labeling ofCeU Membranes  with Annexin V-FITC: 
Apoptosis-induced extemalization of phosphotidylserine  (PS)  was  measured 
by  Annexin V-FITC staining, which was  performed as  follows:  after heat shock (l h 
at 40-43°C), CH
RC5 and AuxBl cells (l x 10
6/ml) were washed once with cold PBS. 
Cells were  then  resuspended in  binding buffer (0.1  M HEPES, pH 7.4;  1.4 M NaCI; 
25  mM CaCh) at 37°C at a concentration of 1 x 10
6 cells per ml.  One hundred /LI  of 
the  solution  was  transferred  and  5  /LI  of  Annexin  V-FITC  (BD  Biosciences, 
Mississauga, ON)  was added.  The cells were then  resuspended and incubated for  15 
min  at RT  in  the dark.  Once the incubation was completed, 400 /LI  of binding buffer 
was added as weil as 5 /LI of PI (l mg/ITÙ).  Samples were analyzed by f10w cytometry 
as  described previously  (Averill-Bates et  al.,  2005).  The intensities of fluorescence 
emHted by Annexjn V and PI were collected on FLI and FL3 channels, respectively. 56 
DETERMINATION OF APOPTOSIS BY FLUORESCENCE MICROSCOPY 
Hoechst Staining: 
CRRCS and AuxB 1 cells were heated (37-43°C) for 2 h in temperature 
controlled water baths. The FaslFasL antagonist, Kp7-6 (100 {tM) was added 1 h 
before heat treatment, where appropriate.  Thereafter, Hoechst 332S8 (SO{tg/ml) (blue 
fluorescence) (Sigma Chemical Co., St. Louis, MO), which binds to condensed 
chromatin in the nucleus of apoptotic cells, was added for IS min along with S{tM of 
cyclosporin A, to prevent efflux of the Hoechst probe by P-GP.  PI (SO{tg/ml) was 
subsequently added to visualize necrotic cells (red fluorescence) by fluorescence 
rnicroscopy (model IM, Carl Zeiss Canada Ltd, St Laurent, QC) and photographs 
were taken by digital camera (camera 3CCD, Sony DXC-9S0P, Empix Imaging Inc, 
Mississauga, ON). Images were analysed by Northem Eclipse software (Tanel and 
Averill-Bates, 200S). Cells were classified using the following critelia: (a)  li ve cells 
(nonnal nuclei, pale blue chromatin with organized structure); (b) membrane-intact 
apoptotic cells (bright blue condensed or fragmented chromatin); (c) necrotic cells 
(red, enlarged nuclei with smooth nonnal structure) (Lee and Shacter, 1999). The 
fractions of apoptotic and necrotic cells were determined relati ve to the total cells 
(obtained using bright field illumination). At least 300 cells were counted for each 
condition. 
STATISTICS 
Data are presented as means ± standard error of the mean (SEM) from  at least 3 
independent  experiments  perfonned  with  multiple  estimations  per  point.  Statistical 
analysis  for  comparisons  between  the  two  cell  lines  at  each  temperature  was 
performed  with  one-way  analysis  of variance  (ANOVA),  paired Student'st-test, or 57 
Fisher's  least  significant  difference  test,  as  appropriate.  Statistical  comparison 
between the  heat shocked MDR  CHRCS  cells and  non  treated control MDR CHRCS 
cells was made using one-way ANOVA with Dunnett adjustment. Software used was 
JMP  Statistical  Discovery  4.0  (SAS  Institute  Inc.,  Cary,  NC).  Differences  were 
considered statistically significant at P < 0.05. 58 
RESULTS 
Heat shock-induced apoptosis via the death receptor pathway 
The death receptar pathway of apoptosis is  characterized by the activation of 
the  initiator caspase-8 through association of procaspase-8 with death receptors and 
adaptor  proteins  like  FADD.  In  AuxB 1  cells,  FADD  protein  levels  showed  a 
significant decrease in the cytosol (Fig.  lA-B) as  the FADD protein was recruited to 
the DISC during heat shock induced apoptosis.  In  CHRCS ceUs, FADD protein levels 
in the cytosol were higher than in AuxB 1 cells at ail temperatures and showed a slight 
decrease  only  at  43°C  relative  to  37°C  (Fig.  lB).  Following  the  lh  heat  shock 
treatment  at  4l-43°C,  FADD  protein  levels  significantly  increased  at  the  cellular 
membrane level in  both AuxB 1 and CHRCS  cells (Fig.  lC-D).  This increase in  the 
plasma membrane levels of FADD with increasing temperatures was similar in  both 
cell  Iines  (Fig.  lC-D).  Purity of cytoplasmic and microsomal fractions  was 98 and 
92%, respectively (Fig. lE). 
Cleavage of procaspase-8 was also investigated by assessing protein levels of 
procaspase-8 with increasing temperatures.  It was found that, although, AuxB 1 cells 
show a significant decrease in procaspase-8 levels with increasing temperatures from 
41  to 43°C, this trend is also present in CHRCS cells (Fig. 2A-B) to a lesser extent.  A 
significant increase in enzymatic activitYofcaspase-8 was detected in AuxB1 cells at 
42-43°C  (Fig.  2C).  There was  a  2-fold increase  in  activity  at  43  oC.  However, 
CHRCS  ceUs  responded  differently  to  heat  shock,  with  no  initial  activation  of 
caspase-8 at temperatures of 40-42°C followed by a  2.S-fold increase in  activity at 
43°C  (Fig.  2C).  The  activity  of two  other  initiatar  caspases  was  also  assessed, 
caspase-lO and -2, which both showed a significant increase in acüvity at 42-43°C in 
AuxB 1 cells and at 43°C in CHRCS cells, compared to 37°C (Fig. 3A-B). 
In  arder to assess the molecular rnechanisrns of heat shock induced apoptosis 
in  MDR  CHRCS  compared  to  their  drug  sensitive  counterparts  AuxB 1  cells,  it  is 
important to consider any differences that rnay exist between the two cell lines due to 59 
selection for MDR.  Thus, the  relative expression of several  pro- and  anti-apoptotic 
proteins  in  the  death  receptor  mediated  pathway  was  measured  and  sorne  variance 
was  observed in  total  protein  levels  between  the  two  cell  lines.  CRRCS  cells show 
slightly higher mean levels of endogenous proteins for both c-FLIPs and c-FLIPL and 
slightly lower mean  levels  of endogenous FADD  protein, compared to  AuxB 1 cells 
(Fig. 4A-E). 
Cleavage ofpro-apoptotic protein Bid in heat shock-induced apoptosis 
A  converging  point  exists  between  the  extrinsic  and  intrinsic  apoptotic 
pathways.  This point involves the cleavage of pro-apoptotic protein Bid into tBid  by 
active  caspase-8.  The  tBid  can  then  translocate  to  the  mitochondrial  membrane 
where  it  can  induce  or  amplify  mitochondria-mediated  apoptosis.  A  graduaI 
significant decrease in  Bid protein levels was observed in  the cytosol with increasing 
temperatures of 41-43°C  in  both  cell  lines  (Fig.  SA-B).  There was  a corresponding 
significant  increase  in  tBid  in  mitochondria  of  AuxBl  cells  at  41-43°C,  and  a 
tendency  to  increase  in  CRRCS  cells  (Fig.  SC-D).  Purity  of  cytoplasmic  and 
mitochondrial fractions  was  98  and  97%,  respectively (Fig.  lE).  CRRCS  cells  have 
significantly higher Bid  levels in  the  cytosol at 37°C, compared ta AuxB 1 cells, and 
undergo  a higher  overall  decrease  in  Bid  levels  with  increasing  temperatures  (40­
43°C) (Fig. SB). 
Reat shock-induced apoptosis via the mitochondrial pathway 
The mitochondrial pathway of apoptosis involves the release of cytochrome c, 
among other pro-apoptotic  molecules, from  mitochondria into  the  cytosol,  where  it 
associates  with  Apaf-l  and  procaspase-9  leading  to  activation  of caspase-9.  The 
release of pro-apoptotic  proteins from  the  mitochondria  is  mediated either by  other 
upstream  pro-apoptotic  proteins,  such  as  Bax  and/or  by  mitochondrial  membrane 
depolarization  via  the  opening of the  permeability transition  pore.  As  illustrated  in 
Fig.  6A-D, there  was  significant  induction  of Bax  translocation from  the  cytosol  to 60 
the  outer mitochondrial  membrane in  both  AuxB 1 and CHRCS  cells upon  1 h  heat 
shock  treatment  at  41-43°C.  At  37°C,  the  level  of Bax  appears  to  be  higher  in 
mitochondria in  CHRCS  than  in  AuxB 1 cells.  Depolarization of the mitochondrial 
membrane in both celllines induced a shift in JC-l fluorescence from the FL2 to FLI 
channel in  response to  increasing temperatures of 40-43°C (Fig.  7A-E, 7G-K).  The 
relative  fluorescence  indicating  mitochondrial  membrane  potential  showed  a 
significant decrease in membrane potential in both cell lines in response to  heat, using 
p-(trifluoro-methoxy)  phenylhydrazone  (FCCP)  as  a  positive  control  (Fig. 
7F,7L,7M).  Depolarization of mitochondrial membrane potential  was significant at 
temperatures of 42-43°C in CHRCS and 41-43°C in AuxB 1 cells (Fig. 7M). 
These  events  were  followed  by  the  release  of  cytochrome  c  from  the 
mitochondria into the cytosol.  A well-defined, significant decrease in  cytochrome c 
levels occurred in  the mitochondria at  41-43°C, with  a corresponding increase in  the 
protein in  the cytosol in  response to  heat shock (Fig.  8A-D).  Enzymatic activity of 
caspase-9 exhibited a similar increase in  both cell lines at 42-43 oC  (Fig. 9A).  There 
was a 3 -fold increase in  activity in  AuxB 1 and CHRCS  cells at 43°C, relative to  the 
control at 37°C. This was confinned by a graduai and similar decrease in procaspase­
9  protein  levels in  the cytosol with  increasing temperatures of 41-43 oC,  in  AuxB 1 
and CHRCS cells (data not shown). 
The  relative  expression  of several  pro- and  anti-apoptotic  proteins  10  the 
mitochondria mediated pathway was also measured and sorne variance was observed 
in  total  protein levels between the two cell  lines.  CHRCS  cells show slightly lower 
mean  levels of endogenous proteins of cytochrome c  and procaspase 9  and  higher 
mean levels endogenous Apaf-l protein (Fig.  lOA-E). 
Activation  of effector caspases-3  and -7 and cleavage  of their substrates  in  heat 
shock-induced apoptosis 
Effector caspases such as  caspase-3 and -7  play a critical  role in  disassembly 
of the  cell  during  later  stages  of apoptosis.  Following exposure  to  heat shock,  a 61 
graduai  increase in  activity of caspase-3 was observed with  increasing temperatures 
of 42-43°C in  AuxB1  and CRRCS cells (Fig.  llA).  A significant 4-fold increase in 
activity was  observed in  both  cell  \ines  at 43°C.  There was  a  decrease in  protein 
levels of procaspase-3 with  increasing temperatures in  AuxB 1 cells,  and to  a lesser 
extent  in  CRRCS  cells  (data  not  shown).  The  activity  of caspase-7  followed  a 
somewhat different trend  with  a  graduai,  significant increase  in  activitY in  AuxB1 
cells, yet, almost no activation with heat shock in CRRCS cells (Fig.  lIB). 
Once activated, effector caspases cleave many different substrates including 
other procaspases, propelling the  process  of apoptosis.  Caspase-3,  being the  main 
effector caspase  involved  in  apoptosis,  cleaves  many  important  substrates,  which 
leads to  the irreversible destruction of the cell.  Two of these substrates, PARP and 
ICAD  are  involved  in  nuclear chromatin  fragmentation  and  condensation.  PARP 
(116  kDa)  is  c1eaved  into  two  fragments  of 8S  and  24  kDa  by  caspase-3.  The 
cleavage  of PARP  was  evaluated  by  measuring  protein  levels  of  PARP  and  its 
fragment  in  the cytosol.  A  significant decrease in  full  length PARP was found  in 
response  to  2  h  heat shock temperatures  of 41-43°C  in  CRRCS  cells  and 43°C  in 
AuxB1  cells  (Fig.  12A-B).  ICAD (47  kDa)  is  norrnally  an  inhibitor of CAD and 
displays  its function  by binding CAD and  rendering it  unable to  cross the  nuclear 
membrane and carry out its  pro-apoptotic effects on chromatin in  the nucleus.  The 
cleavage of ICAD by caspase-3 releases CAD and allows it  to  degrade DNA leading 
to apoptosis.  Levels of ICAD in  the cytosol significantly decreased with exposure to 
increasing temperatures of 41-43 oC  for 2  h  in  both  AuxB1  and CRRCS  cells (Fig. 
12C-D). 
The  relative  expressIon  of  several  pro- and  anti-apoptotic  proteins  was 
measured and sorne variance was observed in total protein levels between the two cell 
\ines.  CRRCS  cells  display  lower  endogenous  protein  levels  of cIAP-1  and  -2, 
Survivin and RSP70; and higher endogenous protein levels of RSP27 (Fig. 13A-I). 62 
Apoptosis levels in AuxBI and CHRCS cells 
Aside from  the involvement of particular pro- and anti-apoptotic  proteins  in 
heat shock  induced cell  death, it  is  equally important to  have a  global  view of the 
levels of apoptosis in  both AuxB 1 and eR
Re5 cells, confirming the event.  For this 
purpose, the levels of apoptosis in  both cell  Iines  were measured using Annexin V­
FITe as  a  marker of apoptosis.  Both cell  lines  exhibit an  increase in  apoptosis  at 
temperatures of 42-43°e, compared to 37°e (Fig.  14A-K).  It is important to note that 
levels  of apoptosis  are  significantly  higher in  eRRe5 than  in  AuxBl  cells  at  ail 
temperatures. 
Further,  nuclear chromatin condensation of apoptotic cells  was  investigated 
using Roechst staining  and  visualized  by  fluorescent  microscopy.  Both  cell  lines 
exhibit a significant increase in  apoptosis at temperatures of 41-43°e with no  initial 
apoptosis in  both  cell  Iines  at  37  and 40
0e  (Fig.  15A-F).  In  comparison  to  cells 
treated only with  heat shock, the cells treated with FasfFasL antagonist show lower 
levels of apoptosis at temperatures of 41-43°e (Fig.  15A-F).  Low levels of necrosis 
were detected at 37  to 43°e compared to  apoptosis,  with  no  significant differences 
between the two cell types (Fig. 15G). 63 
DISCUSSION 
This study shows the  molecular mechanisms of heat shock induced apoptosis 
in MDR CHRCS  cells relative to  their drug-sensitive counterparts CHO AuxB 1 cells. 
A detailed approach, encompassing the key players in  both the extrinsic and intrinsic 
apoptotic pathways, was  taken.  The study shows that heat shock of 42 and 43°C  for 
1-2 h is sufficient to induce apoptosis involving receptor and mitochondrial pathways, 
activation of caspases and cleavage of their substrates.  The study also illustrates that 
heat shock alone can induce apoptosis in MDR CHRCS cells.  It is clear that there are 
differences between drug-sensitive and MDR cells in  the induction of apoptosis with 
heat.  These differences can be seen mainly in  the extrinsic pathway as weIl  as at the 
level of endogenous expression of several apoptotic proteins. 
The effects of heat  shock  on  key  players  in  the  receptor mediated  pathway, 
mainly FADD and procaspase-8, differ between AuxBl and CHRCS cells.  In CHRCS 
cells,  cytosolic  levels  of FADD  and  procaspase-S  proteins  remain  relatively  high 
despite heat shock even at 43°C.  This may point to sorne differences in the apoptotic 
machinery of the MDR CHRCS cells as it has been shown in the past that the cleavage 
of pro-caspase-S  was  completely  blocked  in  human  leukemia  T-cells  resistant  to 
treatment,  although  it  was  unperturbed  in  parental  cells  (Friesen  et  al.,  1996). 
Nevertheless,  despite  higher  trends  in  the  cytosol  of CHRCS  cells,  translocation  of 
FADD to  the plasma membrane is simiJar in  the  two cell  lines, increasing gradually 
with  increasing  temperatures.  CHRCS  cells  exhibit  much  lower caspase-8  activity 
than AuxBl cells at 40-42°C.  However, the main difference is that caspase-S activity 
increases  only  at  43°C  in  CHRCS  cells,  thus  the  graduai  heat  induced  increase  in 
caspase activation seen at  milder temperatures in  AuxB 1 cells is  mjssing here. These 
results show that CHRCS cells are resistant to  heat shock temperatures in terms of the 
receptor  mediated  pathway  and  show  defects  in  receptor-mediated  apoptotic 
machinery.  Another impoltant difference is  the  higher endogenous levels of c-FLIP 
protein in CHRCS cells, which  may point to another mechanism of resistance in  these 64 
cells  to  heat  shock  induced  receptor  mediated  pathway  of  apoptosis.  c-FLIP 
functions  as  an  inhibitor  of caspase-8,  preventing  its  activation  at  the  DISC  via 
binding site competition.  This could explain the lower caspase-8 activity in CH
RC5 
cells.  However,  recently  it  has  been  found  that  under  certain  conditions  where 
cellular levels of FLIPL are high, it may act as an  activator of caspase-8 (Chang et al., 
2002; Micheau et al., 2002; Boatright et al., 2004).  The involvement of the Fas death 
receptor pathway in  heat shock induced apoptosis in  both  AuxB 1 and CH
RC5  cells 
was assessed using the FasIFasL antagonist by fluorescent microscopy using Hoechst 
33258.  It appears that the Fas receptor pathway plays an  important role as  levels of 
apoptosis in response to heat shock decrease in FasIFasL antagonist treated cells. 
Moreover,  it  has  been  previously  shown  that  CH
RC5  cells  have  a  higher 
content of P-GP in  their plasma membrane than  AuxB 1 ceUs  (Turcotte and Averill­
Bates,  2001).  P-GP is  localized  to  membrane  microdomains,  which  are  detergent 
resistant  (detergent  resistant  membranes,  DRMs)  and  up-regulated  in  MDR  cells 
(Lavie et al.,  1998; Liscovitch and Lavie, 2000).  DRMs are made of lipid rafts and 
caveolae,  which  are  laterally  separated  into  cholesterol- and  sphingolipid-rich 
domains of the plasma membrane (Simons and Toomre, 2000; Razani  et al.,  2002; 
van  Meer, 2002).  These microdomains  are  relatively rigid  and  less  fluid  than  the 
surrounding plasma membrane,  which is  partly caused  by  their cholesterol content 
(London  and  Brown,  2000).  Lipid  rafts  are  highly  dynamic  and  prone  to  rapid 
assembly and disassembly, contributing to  dynamic protein segregation (Simons and 
Tomme, 2000; Fasterberg et al., 2003).  Raft localization has been shown to modulate 
an  array of proteins such as  receptor function  and  activity (Gimpl et al.,  1997), and 
ATPase activity of P-GP (Rothnie et al., 2001; Garrigues et al., 2002).  P-GP appears 
to  exist in  its more active state when localized inside lipid rafts (Ghetie et al., 2004) 
and membrane fluidization has been shown to impair P-GP function (Sinicrope et al., 
1992; Ragev et al.,  1999).  Moreover, acute depletion  of cholesterol impacts P-GP 
mediated drug transport in  a  substrate- and cell-type-specific manner (Luker et al., 
2000).  A  recent study showed  that  cholesterol  depletion  removes  P-GP from  raft 65 
membranes  into  non  DRM  fractions,  whereas  repletion  fully  reconstitutes  raft 
localization.  Furthermore, cholesterol depletion reduces P-GP function in MDR cells 
resulting  in  intraceIIular  substrate  accumulation  (Troost  et  aI.,  2004).  It  has  been 
shown  by  Elyassaki  and  Wu  (2004)  that  Iipid  rafts  are  involved  in  mediating UV­
induced Fas  receptor aggregation,  independently  of Fas  ligand.  The study  showed 
that stress by UV impacted the composition of lipid rafts by reducing cholesterol and 
increasing ceramide levels.  The  compositional  change resulted  in  the  cIustering of 
Iipid  rafts,  resulting in  aggregation of FasR, which  led  to subsequent recruitment of 
FADD and activation of caspase-8. 
It  has  been  recently  suggested  that  one  mechanism  of  FasR-mediated 
apoptosis might be  via change in  membrane composition, due to  an  extemal stressor, 
particularly  an  increased  clustering  of  Iipid  rafts.  It  may  be  that  this  is  a  major 
mechanism  by  which  receptor-mediated  apoptosis  in  response  to  stressors  like  UV 
and  heat shock occurs in  ceIIs.  Cellular membranes, particularly plasma membrane 
are known to undergo temperature-induced "disorganization" to a point where a Iipid 
transition causes a membrane structural change,  which  results  in  cell death  (Yatvin, 
1977;  Yatvin  et  al,  1987;  Yatvin,  1987;  Yatvin  and  Cramp,  1993).  Endogenous 
levels  of FasR  protein  do  not  differ  between  AuxB1  and  CH
RC5  cells.  However, 
since  MDR  CH
RC5  ceUs  contain  higher  levels  of P-GP  in  their  plasma  membrane 
than  AuxB1  cells  and  that  P-GP  is  localized  and  more  active  in  lipid  rafts,  then 
perhaps high levels of P-GP present in  lipid rafts in  the plasma membrane of CH
RC5 
cells  could  interfere  in  the  recruitment  of FasR  into  Iipid  rafts  in  response  to  heat 
shock and thus the activation of the receptor mediated pathway of apoptosis in  these 
cells.  Yet, a decrease in cholesterol, as seen with UV stress, should render P-GP non 
functional,  sequestering it from  the Iipid rafts.  It  has  previously been shown that the 
reduction in cholesterol is not dependent on UV-dosage, but it cannot be rebuked that 
it  is  not  dependent  on  temperature.  In  the  future,  this  avenue  needs  to  be  more 
cIosely investigated, in  order to establish the role of heat shock in  P-GP function and 
plasma membrane cholesterol levels. 66 
It is equally important to note that FasR aggregation does not necessarily have 
to  correlate with Fas-mediated apoptosis.  It has  been  shown in  the past that -these 
events  are  not directly  correlated  and  may  even  be  inversely  correlated  (Lee  and 
Shacter, 2001).  Furthermore, one must consider the raIe of ceramide in induction of 
apoptosis in  response to  heat shock.  Ceramide is  extensively involved in  apoptosis 
via several routes.  One route involves initiation of apoptosis by permeabilization of 
the mitochondrial outer membrane to  pro-apoptotic prateins, such as  cytochrame c, 
AIF  and  SmaclDIABLO  which  are  located  in  the  intermembrane  space.  This 
permeabilization can be performed by ceramide directly because ceramides are able 
to form channels in  planar phospholipid membranes (Siskind and Colombini, 200S) 
and in liposomes (Stiban et al., 2006). 
Several  pro-apoptotic  changes  were found  in  CHRCS  cells,  which  may 
compensate for resistance observed in  the receptor-mediated pathway in  these cells. 
Differences  in  the  mitochondria-mediated  pathway  of  apoptosis  in  AuxB 1  and 
CHRCS  cells in  response to  heat shock can be observed.  Bax pratein levels in  the 
mitochondria of CHRCS cells are higher than those in  AuxB 1 cells and only a slight 
increase with increasing temperature can be observed.  Translocation of Bax from the 
cytosol  to  the mitochondria,  where Bax oligomerizes into a  high  molecular weight 
complex, leads to  the permeabilization of the mitochondrial outer membranes (Eskes 
et al., 2000; Antonsson et al., 2001; Kuwana et al.,  2001).  Bax was  also shown to 
interact with  voltage-dependent anion  channel  (VDAC) (Shimizu et al.,  1999)  and 
adenine  nucleotide  translocator (Marzo et  al.,  1998),  which  partially compose the 
mitochondrial permeability transition pore.  Thus, Bax may function in mitochondria 
by  facilitating  the  opening  of  the  mitochondrial  permeability  transition  pore 
eventually leading  to  mitochondrial  swelling,  rupture  of the  outer  membrane  and 
release of several pro-apoptotic proteins.  Endogenous levels of proapoptotic protein 
Apaf-l, which normally constitutes the apoptosome and is crucial for the execution of 
the mitochondria mediated apoptotic pathway, were elevated in  CHRCS compared to 
AuxB 1  cells.  These  observations  along  with  earlier  results  may  point  to  the 66 
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dominance of the mitochondria-mediated pathway in heat shock-induced apoptosis in 
these  MDR  cells.  Further,  a  temperature  dependent  decrease  in  mitochondrial 
membrane potential can be seen in both AuxB 1 and CHRCS cells. 
Crosstalk between the receptors and the mitochondria occurs during apoptosis 
via  the  pro-apoptotic  protein  Bid  that  is  nonnally  cleaved  to  tBid  by  activated 
caspase-S.  Despite lower activity of caspase-S in CHRCS cells, Bid cleavage and tBid 
translocation to the mitochondria is similar to that in AuxB 1 cells.  Thus, the cleavage 
of Bid may be attributed to other proteases such as caspase-2 and -10 (Bonzon et al., 
2006; Fischer et al., 2006; Milhas et al., 200S).  The activation of these caspases, as 
well as  caspase-S, with heat shock confinns their involvement in  heat shock induced 
apoptosis  in  both  AuxB 1  and  CHRCS  cells.  Although  not  significant,  the 
mitochondrial  membrane  potential  appears  to  be  slightly  lower in  CHRCS  than  in 
AuxB 1 decreasing even further with heat shock.  This suggests that CHRCS cells have 
a pro-apoptotic tendency and this may be attributed to  lower levels of anti-apoptotic 
proteins such as HSP70, Survivin and cIAPs. 
Other differences between AuxB1  and CHRCS  cells can be  seen downstream 
of  the  heat  shock  induced  initiation  of either  the  receptor- and/or  mitochondria­
mediated pathways of apoptosis.  Procaspase-3 protein levels are generally higher in 
CHRCS  than  in  AuxB1  cells  and  remain  fairly  high  even  with  heat  shock 
temperatures of 42 and  43°C.  However, caspase-3 activity correlates well  between 
the  two  cell  lines  and  in  CHRCS  cells  does  not  reflect  the  lower  cleavage  of 
procaspase-3.  This does not necessarily point to a mechanism of resistance in CHRCS 
cells as it has been previously shown that caspase activity does not always correlate 
with  procaspase cleavage  (Salvesen  and  Dixit,  1999).  Further,  caspase-7  activity 
remains relatively constant in  CHRCS  cells  while it  increases in  AuxB1  cells  with 
increasing temperature.  However,  like caspase-3, caspase-7  is  an  effector caspase 
and although it has many substrates for cleavage it shares most of them with caspase­
3  (Eamshaw et al.,  1999).  Therefore, caspase-7  does  not appear to  play a  role  in 
downstream events of apoptosis in response to heat shock in CHRCS cells. 68 
Finally, the difference in the percentage of apoptosis seen between AuxB 1 and 
CH
RC5 cells  using Annexin  V  binding implies that  MDR CH
RC5  cells  have much 
higher levels of apoptosis even under control  conditions of 37°C.  Annexin V  is  a 
fluorescent dye that binds extemalized phosphatidylserine (PS).  Phosphatidylserines 
normally reside on  the inner leaflet of the plasma membrane bilayer, however, upon 
induction of apoptosis they f1ip  to the outside of the plasma membrane and are able to 
selectively bind Annexin V.  This is not possible in  vital cells where PS is confined to 
the cytosolic face of the plasma membrane.  It has recently been found that P-GP, in 
addition to  its drug transporter function, can also act as  a f1ippase  of phospholipids, 
such  as  PS,  and  by  remaining  mobile  in  the  phospholipid  bilayer of the  plasma 
membrane it  contributes to  the  asymmetric lipid distribution  in  the outer and inner 
leaflet  of the  bilayer  (Romsicki  and  Sharom,  2001;  Pohl  et  aL,  2002;  van  Meer, 
2002).  Thus, the high levels of AnnexinV-PS fluorescence in  MDR CH
RC5 cells are 
misleading and  appear to  be  due to  the  presence of increased amounts of P-GP in 
their plasma membrane and not necessarily to a higher percentage of apoptotic cells. 
Our  results  confirm  that  Annexin  V  cannot  be  used  as  an  accurate  indicator  of 
apoptosis in P-GP overexpressing cells.  Nevertheless, overall both cell lines respond 
identically to heat shock induced apoptosis. 
In  order to  get a  better indication of apoptotic  levels in  MDR CH
RC5  cells, 
fluorescence ffiicroscopy using Hoechst 33258 stain was used.  Hoechst 33258 binds 
to condensed chromatin in the nucleus of apoptotic cells thus giving an  assessment of 
apoptotic levels independent of P-GP function.  The results showed no differences in 
apoptosis in either AuxBI or CH
RC5 cells at temperatures of 37 and 40°C as was seen 
with Annexin V, and apoptosis was shown at 41-43°C.  Apoptotic levels appear to be 
higher in  CH
RC5  then in  AuxBI  cells at  42-43°C.  This may be  attributed to  lower 
endogenous levels of anti-apoptotic proteins such as lAPs and Survivin in  these cells. 
The trend for heat shock induced apoptosis is  remarkably similar in  both cell  lines, 
whether assessed by Hoechst staining or Annexin V and in  both cases CH
RC5 ceUs 69 
appear  to  compensate for  their differences  in  importance of apoptotic  pathways  to 
give an overaU nearly identical response as the parental ceUs. 
In conclusion, there is variance in  heat shock induced apoptosis between drug­
sensitive AuxBl and MDR CHRCS ceUs.  It appears that CHRCS ceUs are resistant to 
heat  shock  via  the  receptor  mediated  pathway  of  apoptosis.  Differences  in 
endogenous expression of anti-apoptotic proteins such as c-Flip may play a role in the 
mechanism of receptor mediated  resistance to  heat shock induced apoptosis in  these 
ceUs.  The results suggest that the mitochondria mediated pathway of apoptosis is the 
main  route of heat shock induced cel\ death  in  CHRCS  cells.  Downstream effects of 
heat induced apoptosis, such as the activation of caspase-3 and cleavage of ICAD and 
PARP, imply that CHRCS cells respond as equally to heat shock induced apoptosis as 
AuxBl  cells.  Heat  shock  or  hyperthermia  is  already  being  used  in  the  clinic  in 
combination  with  chemotherapy or radiotherapy aiming to  once again  render tumar 
cells  sensitive  to  these  cytotoxic  treatments.  This  has  been  relatively  successful, 
however, the molecular mechanisms by  which  heat  may sensitize tumor cells to  cell 
death is not weil  understood.  A useful benefit of hyperthermia in  the cancer clinic is 
that it has the potential to directl y kill  MDR cel\s.  The consequences of the presence 
of  P-GP  in  MDR  cells  have  not  aU  been  elucidated.  Understanding  of  the 
mechanisms of P-GP-dependent MDR in  response to heat wou Id  be highly beneficial 
when  designing patient treatments.  This  is  the  first  in  vitro study  which  shows  the 
molecular  mechanisms  of heat  shock  induced  apoptosis  that  differ  between  drug 
sensitive AuxBlcells and MDR CHRCS ceUs overexpressing P-GP. 70 
Acknowledgements: 
The  authors  wish  to  thank  Ahmed  Bettaieb,  Michel  Marion  and  Denis  Flipo  for 
valuable  technical  assistance  and  Bernard  Fournier  (SCAD)  for  assistance  with 
statistical analysis.  This work was supported by grants from the Natural Sciences and 
Engineering Research Council of Canada (NSERC) (DAB). 71 
REFERENCES 
1.	  Antonsson B, Montessuit S, Sanchez B, Martinou, Je. 2001. Bax is present as 
a high molecular weight oligomer/complex in  the mitochondrial membrane of 
apoptotic cells. J Biol Chem 276:11615-11623. 
2.	  Aouali  N,  Morjani  H, Trussardi  A,  Soma E,  Giroux  B,  Manfait M.  2003. 
Enhanced  cytotoxicity  and  nuclear  accumulation  of  doxorubicin-Ioaded 
nanospheres  in  human  breast cancer MCF7 cells  expressing MRPI.  lnt  J 
Gncol 23: 1195-201. 
3.	  Averill DA, Larrivee B.  1998. Hyperthermia, cyclosporine A and melphalan 
cytotoxicity  and  transport  in  multidrug  resistant  cells.  lnt J  Hyperthermia 
14:3-8. 
4.	  Averill DA, Su C.  1999.  Sensitization to  the cytotoxicity of Adriamycin  by 
verapamil and heat in  multidrug-resistant Chinese hamster ovary cells. Radiat 
Res 151 :694-702. 
5.	  Averill-Bates DA, Cherif A,  Agostinelli E, Tanel  A,  Fortier G.  2005.  Anti­
tumoral  effect of native  and  immobilized bovine serum amine oxidase in  a 
mouse melanoma model. Biochem Pharmacol 69:1693-704. 
6.	  Bates DA, Mackillop WJ.  1990. The effect of hyperthermia in  combination 
with melphalan on  drug-sensitive and drug-resistant CHG cells in  vitro. Br J 
Cancer 62: 183-188. 
7.	  Bates  DA,  Mackillop Wl 1986.  Hyperthermia,  adriamycin  transport,  and 
cytotoxicity  in  drug-sensitive  and  -resistant  Chinese  hamster  ovary  cells. 
Cancer Res 46:5477-81. 
8.	  Bamhart BC, Alappat EC, Peter ME. 2003.  The CD95 type I/type II model. 
Sernin lmmunol 15: 185-93. 
9.	  Bettaieb  A,  Avetill-Bates  DA.  2005.  Thermotolerance  induced  at  a  mild 
temperature  of  40  degrees  C  protects  cells  against  heat  shock-induced 
apoptosis. J Cell Physiol 205:47-57. 
10. Bradford MM.	  1976.  A  rapid  and  sensitive method for the quantitation of 
microgram quantities of protein utilizing the plinciple of protein-dye binding. 
Anal Biochem 72:248-54. 72 
Il. Boatright  KM,  Deis  C,  Denault  JB,  SutherIin  DP,  Salvesen  GS.  2004. 
Activation of caspases-8 and -10 by FLIP(L). Biochem J 382:651-7. 
12. Bonzon C, Bouchier-Hayes L, Pagliari LJ, Green DR, Newmeyer DD. 2006. 
Caspase-2-induced Apoptosis Requires Bid Cleavage: A Physiological Role 
for Bid in Heat Shock-induced Death. Mol Biol Cell 5:2150-7. 
13. Boreham DR, Dolling JA, Maves SR, Miller S, Morrison DP, Mitchel RE. 
1997. Heat-induced thermal tolerance and radiation resistance to apoptosis in 
human lymphocytes.Biochem. Cell Biol 75:393-7. 
14. Chang	 DW, Xing Z,  Pan  Y,  Algeciras-Schimnich  A,  Bamhart BC,  Yaish­
Ohad S, Peter ME, Yang X.  2002. c-FLIP(L) is a dual function regulator for 
caspase-8 activation and CD95-mediated apoptosis. EMBO J 21:3704-3714. 
15. De Wit R,  Van der Zee J, Van der Burg MEL.  1999.  A  phase VII  study of 
combined weekly systemic cisplatin and locoregional hyperthennia in patients 
with  previously  irradiated  recurrent  carcinoma  of the  uterine  cervix.  Br  J 
Cancer 80: 1387-1391. 
16. Darzynkiewicz Z,  Bruno S, Del	 Bino G, Gorczyca W, Hotz MA, Lassota P, 
Traganos F.  1992.  Features of apoptotic cells  measured by f10w  cytometry. 
Cytometry 13:795-08. 
17. Dudley  W,  Lamming JR.  1998.  Apoptosis  in  LR73  Cells  is  Inhibited  by 
Overexpression of the multidrug resistance (MDR) protein. J  Undergrad Sci 
3: 127-134. 
18. Dumontet  C,  Bodin  F,  Michal  Y.  1998.  Potential  interactions  between 
antitubulin agents and temperature: implications for modulation of multidrug 
resistance.  Clin Cancer Res 4: 1563-6. 
19. Elyassaki W,	 Wu S.  2006. Lipid rafts  mediate ultraviolet light-induced Fas 
aggregation in M624 melanoma cells. (Epub ahead of print) 
20. Eamshaw  WC,  Martins  LM,  Kaufmann  SH.  1999.  Mammalian  caspases: 
structure,  activation,  substrates  and  functions  during  apoptosis.  Annu  Rev 
Biochem 68:383-424. 
21. Eskes  R,	 Desagher  S,  Antonsson  B,  Martinou  Je.  2000.  Bid  induces  the 
oligomerization and insertion of Bax into the outer mitochondrial membrane 
Mol Cell Biol 20:929-935. 
22. Fastenberg ME, Shogomori H, Xu X, Brown DA, London E. 2003. Exclusion 
of a transmembrane-type peptide from ordered-Iipid domains (rafts) detected 
by fluorescence quenching: extension of quenching analysis to account for the 
effects of domain size and domain boundaries. Biochemistry 42: 12376-12390. 73 
23. Fischer U, Stroh C, Schulze-Osthoff K. 2006. Unique and overlapping 
substrate specificities of caspase-8 and caspase-l0. Oncogene 1:152-9. 
24. Fraker DL. 2004.  Management	  of in-transit melanoma of the extremity with 
isolated limb perfusion. Curr Treat Options Oncol 3: 173-84. 
25. Friesen C, Herr l, Krammer PH, Debatin KM.  1996. Involvement, of the CD­
95 (APO-llFas) receptor/ligand system in drug-induced apoptosis in  leukemia 
cells. Nat Med 2:574-577. 
26. Garrigues A, Escargueil AE, Orlowski S.  2002. The multidrug transporter, P­
glycoprotein,  actively  mediates  cholesterol  redistribution  in  the  cell 
membrane. Proc Natl Acad Sci USA 99: 10347-10352. 
27. Ghetie MA, Marches R,  Kufert S, Vitetta ES.  2004.  An	 anti-CDl9 antibody 
inhibits  the  interaction  between P-glycoprotein  (P-glycoprotein)  and  CDI9, 
causes P-glycoprotein to  translocate out of Iipid  rafts and chemosensitizes a 
multidrug-resistant CMDR) lymphoma cellline. Blood 104:178-183. 
28. Gimpl G, Burger K, Fahrenholz F.  1997. Cholesterol as modulator of receptor 
function. Biochemistry 36: 10959-10974. 
29. Hildebrandt B, Drager J, Kerner T, Deja M, Loffel J, Stroszczynski C, Ahlers 
0, Felix R, Riess H, Wust P. 2004a. Whole-body hyperthermia in the scope of 
von  Ardenne's  systemic  cancer  multistep  therapy  (sCMT)  combined  with 
chemotherapy in  patients with metastatic colorectal cancer: a phase VII study. 
Int J Hyperthermia 20:317-333. 
30. Hildebrandt B, Wust P, Gellermann J, Nicolaou A, Trappe RU, Felix R, Riess 
H,  Rau  B.  2004b.  Treatment of locally  recurrent rectal  cancer with  special 
focus on regional pelvic hyperthermia. Oncology 5:506-511. 
31. Issels	  RD,  Avdel-Rahman  S,  Wendtner  CM.  2001.  Neoadjuvant 
chemotherapy  combined  with  regional  hyperthermia  (RHT)  for  locally 
advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of 
adults: long-term results of phase II study. Eur J Cancer 37: 1599-1608. 
32. Jones	 EL,  Oleson  JR,  Prosnitz  LR,  Samulski  TV,  Vujaskovic  Z,  Yu  D, 
Sanders  LL,  Dewhirst  MW.  2005.  Randomized  trial  of hyperthermia  and 
radiation for superficial tumors. J Clin Oncol 23:3079-85. 
33. Juranka	 PF,  Zastawny  RL,  Ling  V.  1989.  P-glycoprotein:  multidrug­
resistance  and  a  superfamily  of  membrane-associated  transport  proteins. 
FASEB J 3:2583-92. 74 
34. Kim KS.  2002.  Multifunctional role of Fas-associated death domain protein 
in apoptosis.  J Biochem Mol Biol 35:1-6. 
35. Kuwana T, Mackey MR, Perkins G, El!isman MH, Latterich M, Schneiter R, 
Green  DR,  Newmeyer DD.  2002.  Bid,  Bax,  and  lipids  cooperate  to  form 
supramolecular openings in the outer mitochondrial membrane. Cel! 111 :331­
342. 
36. Laemmli UK.  1970.  Cleavage	 of structural  proteins during  the assembly of 
the head of bacteriophage T4. Nature 227:680-685. 
37. Larrivée B,  Averill  DA.  2000.  Modulation	 of Adriamycin cytotoxicity and 
transport  in  drug-sensitive  and  multidrug-resistant  Chinese  hamster  ovary 
cel!s  by  hyperthermia  and  cyclosporin  A.  Cancer  Chemother  Pharmacol 
45 :219-230. 
38. Lavie	 Y,  Fiucci  G,  Liscovitch  M.  1998.  Up-regulation  of  caveolae  and 
caveolar  constituents  in  multidrug-resistant  cancer  ceUs.  J  Biol  Chem 
273 :32380-32383. 
39. Lee Y, Shacter E.  2001. Fas aggregation does not correlate with Fas-mediated 
apoptosis.  J Immunol 167:82-9. 
40. Ling	 V.  1997.  Multidrug  resistance:  molecular  mechanisms  and  clinical 
relevance.  Cancer Chemother PharmacoI40:S3-8. 
41. Ling  V,  Thompson	 LH.  1973.  Reduced  permeability  in  CHO  ceUs  as  a 
mechanism of resistance to colchicine. J Cel1 Physiol 83: 103-16. 
42. Liscovitch  M,  Lavie	 Y.  2000.  Multidrug  resistance:  a  role  for  cholesterol 
efflux pathways? Trends Biochem Sci 25:530-534. 
43. Liu  Y,  LiUehei	 K,  Cobb WN,  Christians  U,  Ng KY.  2001.  Overcoming 
NIDR  by  ultrasound-induced  hyperthermia  and  P-glycoprotein  modulation. 
Biochem Biophys Res Commun 289:62-8. 
44. London E, Brown DA.  2000.  Insolubility	 of lipids in  triton X-100:  physical 
origin and relationship to sphingolipid/cholesterol membrane domains (rafts). 
Biochim Biophys Acta 1508:182-195. 
45. Luker GD, Pica CM, Kumar AS, Covey DF, Piwnica-Worms D. 2000. Effects 
of cholesterol and enantiomeric cholesterol on P-glycoprotein localization and 
function in low-density membrane domains. Biochemistry 39:8692. 75 
46. Marzo	 l,  Brenner C,  Zamzami  N,  Jurgensmeier JM,  Susin  SA,  Vieira HL, 
Prevost  MC,  Xie  Z,  Matsuyama  S,  Reed  JC,  Kroemer  G.  1998.  Bax  and 
adenine  nucleotide  translocator  cooperate  in  the  mitochondrial  control  of 
apoptosis. Science 281:2027-2031. 
47. Micheau	 0, Thome M,  Schneider P,  Holler N,  Tschopp J,  Nicholson DW, 
Briand  C,  Grutter  MG.  2002.  The  long  form  of FUP  is  an  activator  of 
caspase-8  at  the  Fas  death-inducing  signaling  complex.  J  Biol  Chem 
277:45162-45171. 
48. Milhas D, Cuvillier 0, Therville N, Clave P, Thomsen M, Levade T, Benoist 
H,  Segui  B.  2005.  Caspase-10  triggers  Bid cleavage  and  caspase  cascade 
activation in FasL-induced apoptosis. J Biol Chem 20: 19836-42. 
49. Momoi T.  2006.  Conformational diseases and ER stress-mediated cell death: 
apoptotic cell death and autophagie cell death.  Curr Mol Med 6: 111-8. 
50. Nagata S. 2000.  Apoptotic DNA fragmentation.  Exp Cell Res 256: 12-8. 
51. Pohl	 A,  Lage H,  Muller P,  Pomorski  T,  Herrmann  A.  2002.  Transport of 
phosphatidylserine  via  MDR1  (multidrug  resistance  1)  P-glycoprotein  ln  a 
human gastric carcinoma ceilline. Biochem J 365:259-268. 
52. Razani B,  Woodman SE,  Lisanti  MP.  2002.  Caveolae:  from cell  biology  to 
animal physiology. Pharmacol Rev 54:431-467. 
53. Regev  R,  Assaraf  YG,  Eytan  GD.	 1999.  Membrane  fluidization  by  ether, 
other anesthetics and certain agents abolishes P-glycoprotein ATPase activity 
and  modulates efflux from multidrug-resistant cells. Eur J  Biochem 259: 18­
24. 
54. Ringger NC, Tolentino PJ, McKinsey DM, Pike BR,	 Wang KK, Hayes RL. 
2004.  Effects of injury severity on regional and temporal mRNA expression 
levels  of  calpains  and  caspases  after  traumatic  brain  injury  in  rats.  J 
Neurotrauma 21 :829-41. 
55. Robertson	 JD,  Zhivotovsky  B,  Gogvadze  V,  Orrenius  S.  2003.  Outer 
mitochondrial  membrane  permeabilization:  an  open-and-shut  case?  Cell 
Death Differ 10:485-7. 
56. Romsicki	  Y,  Sharom  FJ.  2001.  Phospholipid  flippase  actlvlty  of  the 
reconstituted  P-glycoprotein  multidrug  transporter.  Biochemistry  40:6937­
6947. 76 
57. Rothnie	 A,  Theron  D,  Soceneantu  L,  Martin  C,  Traikia  M,  Berridge  G, 
Higgins CF, Devaux PF, Callaghan R. 2001. The importance of cholesterol in 
maintenance  of  P-glycoprotein  activity  and  its  membrane  perturbing 
influence. Eur Biophys J 30:430-442. 
58. Salvesen  OS,  Dixit  VM.	  1999.  Caspase  activation:  the  induced-proximity 
mode\. Proc Natl Acad Sci USA 96: 10964-10967. 
59. Samali A, Cai J, Zhivotovsky B, Jones D, Orrenius S.  1999. Presence of a pre­
apoptotic complex of pro-caspase-3, Hsp60 and HsplO in  the mitochondrial 
fraction of jurkat cells. EMBO J 18:2040-2048. 
60. Shimizu S,  Narita M, Tsujimoto	 Y.  1999. Bcl-2 family proteins regulate the 
release  of apoptogenic cytochrome c  by  the  mitochondrial  channel  VDAC. 
Nature 399:483-487. 
61. Simons K, Toomre D. 2000. Lipid rafts and signal transduction. Nat Rev Mol 
Cell Biol 1:31-39. 
62. Sinicrope  FA,  Dudeja  PK,  Bissonnette  BM,  Safa  AR,  Brasitus  TA.	 1992. 
Modulation of P-glycoprotein-mediated drug transport by alterations in  lipid 
fluidity of rat  liver canalicular membrane vesicles.  J Biol Chem 267:24995­
25002. 
63. Siskind D, Colombini M.  2000. The lipids C2- and Cl6-ceramide form large 
stable channels.  Implications for apoptosis.  J Biol Chem 275:38640-38644. 
64. Stennicke BR, Salvesen OS.  1997. Biochemical characteristics of caspases-3, 
-6, -7, and -8.  J Biol Chem 272:25719-25723. 
65. Souslova	 T,  Averill-Bates  DA.  2004.  Multidrug-resistant  hela  cells 
overexpressing  NIRPI  exhibit  sensitivity  to  cell  killing  by  hyperthermia: 
interactions with etoposide.  Int J Radiat Oncol Biol Phys 60:1538-51. 
66. Stiban J, Fistere D, Colombini M.	  2006. Dihydroceramide hinders ceramide 
channel  formation:  implications  on  apoptosis.  Apoptosis  (Epub  ahead  of 
print) 
67. Tanel A, Averill-Bates DA. 2005. The aldehyde acrolein induces apoptosis 
via activation of the mitochondrial pathway. Biochim Biophys Acta 
1743:255-67. 77 
68. Troost J, Albermann N, Haefeli WE, Weiss 1.  2004. Cholesterol modulates P­
glycoprotein activity in  human peripheral blood mononuclear cells. Biochem 
Biophys Res Commun 316:705-711. 
69. Turcotte  S,	 Averill-Bates  DA.  2001.  Sensitization  to  the  cytOtOXIClty  of 
melphalan  by  ethacrynic  acid  and  hyperthermia  in  drug-sensitive  and 
multidrug-resistant Chinese hamster ovary cells. Radiat Res 156:272-282. 
70. Wendtner CM,  Avdel-Rahman  S,  Baumer 1.  2001.  Treatment  of primary, 
recurrent  or  inadequately  resected  high-risk  soft-tissue  sarcomas  (STS)  of 
adults: results of phase II pilot study (RHT-95) of neoadjuvant chemotherapy 
combined with regional hyperthermia. Eur J Cancer 37:1609-1616. 
71. Wust  P,  Hildebrandt  B,  Sreenivasa  G.  2002.  Hyperthermia  10  combined 
treatment of cancer. The Lancet Oncology 3:487-497. 
72. Van der Zee J.  2002. Heating the patient:  a promising approach? Ann Oncol 
13:1173-1184. 
73. Van	 Meer G.  2002.  Cell  biology. The different  hues  of lipid  rafts.  Science 
296:855-857. 
74. Yakirevich E, Sabo E, Naroditsky l, Soya Y, Lavie 0, Resnick MB. 2006. 
Multidrug resistance-related phenotype and apoptosis-related protein 
expression in ovarian serous carcinomas.  Gynecol Oncol 100: 152-9. 
75. Yatvin MB, Cramp WA. 1993.  Role of cellular membranes in hyperthermia: 
sorne observations and theories reviewed.  Int J Hyperthermia 2: 165-85. 
76. Yatvin MB. 1987.  Influence of membrane-lipid composition on translocation 
of nascent proteins in  heated Escherichia coli.  Biochim Biophys Acta 1:147­
56. 
77. Yatvin MB, Dennis WH, Elegbede JA, Elson CE. 1987. Sensitivity of tumour 
cells to heat and ways of modifying the response.  Symp Soc Exp Biol 
41 :235­
78. Yatvin MB. 1977.	 The influence of membrane lipid composition and 
procaine on hyperthermic death of cells.  Int J Radiat Biol Relat Stud Phys 
Chem Med 6:513-21. 78 
A  Cytosolic FADO Expression 
AuxB1 Cells 
GAPDH 
37 40  41  42  43
 
Heat shock temperature (OC)
 
B
  D AuxB1 Cells
150 
­ C-
•  CHRCS Cells 
._ 0  *b 
:1­ C.p.o
"Cii
o 
8
C 
100 
t/)  .... 
~  0 
a.~ ><  0 
<1>:::­
C  0  50 C  t/J «oS 
u..~  o 
37 40  41 42 43 
Heat shock temperature (OC) 
Figure 1, A-B 79 
C  Plasma Membrane FADD Expression 
AuxB1  Cells 
37 40  41  42  43 
Heat shock temperature (OC) 
D 
ca  250  D AuxB1  Cells 
E~ 
U)  0  *a,c 
ca  :l..  200  •  CH
RC5 Cells - ... a.  C 
.=  8 150 C  ..... 
o  0 
.- ~ 
~ e- 100 
Q)  Q)
 
:l..  C
  a. ca 
><:l..  50 
Q).Q 
c  E  c  Q)  0  ;-""--'--'­
<2:  E  37 40  41  42 43 
LL.  Heat shock temperature (OC) 
E
 
123123123
 
Calnexin 
GST-n1 
Cyt c Oxidase IV 
Figure 1, C-E
 80 
A  Whole Cel! Procaspase-8 Expression 
AuxB1 Cells 
GAPDH 
37 40  41  42  43
 
Heat shock temperature (OC)
 
B o  AuxB1 Cells 
125 
c:  •  CH
RC5 CeUs 
o .­
tn  100 
tn 
Q)­
'-
~ - ,g75
Q)  c: 
co  0 
cl>  (.) 50 
tn~  ns  0 
c.~ o 
~  -25 
(.) 
o 
'­ D..  0  -t--"--'-'-'--'­
37 40  41 42 43 
Heat shock temperature (OC) 
Figure 2, A-B
 81 
C 
300 ­
>~  o AuxB1  Cells 
:;:;  0 
o  ~ 
•  CH
RC5 Cells <t"E  200 
**a 
co  0 
1 0 
(1)  lit­
~  0 
~~  100 
~ 
CJ 
*b  *b  ** b 
0+-------.---------,-----,----------.-------, 
37 40  41  42 43 
Heat shock temperature (OC) 
Figure 2, C
 82 
A
 
.., ~  10  .­
>- o AuxB1 Cells  *a +:(5
o  ~  8  «..,  •  CHRCS Cells 
o g  6 "7  0 
(1)'1­
tJ)  0 
~~  4
0.0 
tJ)­
u 
~  2 
0 
37 40  41  42  43 
Heat shock temperature (OC) 
B 
25  ..,  ~  *a,b .­>- o AuxB1 Cells 
+:  0  20 o  ~ 
•  CHRCS CeUs «E 
C\I
1  0 0  15 
(1)'1­
tJ)  0 
~~  10 
tJ)~ 
u 
~ 
5 
0 
37 40  41  42  43 
Heat shock temperature (OC) 
Figure 3, A-B
 83 
A  Fas R  B  FADD 
5  8 
::I:  4  6 
C 
a.. 
3 
4 
<t  2 
C)  2 
0  ..... 
0  0 
s:::::: 
0 .­
U) 
U)  C  Procaspase-8 
Q)  2 
~ 
Q.  D AuxB1  Cells 
>< 
Q) 
s:::::: .­
1  •  CHRCS Cells 
Q)  ..... 
.... 
0  .... 
~ 
Q.  0 
..  .  .  . 
'1­
0 - D Q)  Short c-Flip  E  Long c-Flip 
>
Q) -
Q) 
> .­ ..... 
: 1 
4  -
3 J 
6 
5 
4 
3 
· .... 
~ - Q)
a:: 
2  2 
· .... 
·  .  .  . . 
0  0­
Figure 4, A-E
 84 
A  C  osolic Bid Expression 
AuxB1 Cells 
GAPDH 
37 40  41  42  43 
Heat shock temperature (OC) 
B 
o  en  200  .... o o AuxB1 Cells 
*b  ~­ o­ •  CHRCS Cells c: e 150 
.- +'" 
c:  C  o 0 
.- en,....
0  100 
en  0
(1) 
10.~
0. 0 
><­ 50 
(1) 
'lJ .­
al 
37 40  41  42 43 
Heat shock temperature (OC) 
Figure 5, A-B
 85 
C  Mitochondrial tBid Expression 
AuxB1 Cells 
37 40  41  42  43 
Heat shock temperature CC) 
D 
o AuxB1 Cells  - 0 
Jo. 
+-'  200  •  CHRCS Cells c c 
.- 0 
c 0 
o'+­
.- 0  150 
tJ) 
tJ)~
 
G)~
 
Jo.  m
0..- 100 X  Jo. 
G)"C 
"C  c  ._  0 
m.c  50 
+-'  0 
0 
+-' .­
E 0
 
37 40  41  42  43
 
Heat shock temperature (OC)
 
Figure 5, C-O
 - -
86 
A  Cytosolic Bax Expression 
AuxB1 CeUs 
GAPDH 
37 40  41  42  43 
Heat shock temperature (OC) 
B 
125  D AuxB1 CeUs 
C 0  •  CHRCS CeUs .- .b 100 
C C  o 0  *a  .- 0 
tJ>  't- 75 
tJ>  0 (1) 
~~  0.0 
><  - 50 
(1)ë 
><  tJ> 
~.s  25 
~ 
() 
37 40  41 42 43 
Heat shock temperature (OC) 
Figure 6, A-B 87 
C  Mitochondrial Bax Expression 
AuxB1 CeUs 
37 40  41  42  43 
Heat shock temperature (OC) 
='0 D AuxB1 CeUs  o .=  250  **a 
c:  c:  •  CHRCS CeUs  *a .- 0 
c:  (J
.- o'+-
0 
200 
tI'J 
tI'J~ 
CI)  - 150 "- co c. ._ 
><  "­
CI)"C 
><  c:  100 
co  0
lD"fi 
.
o -
50 ...
37 40  41  42 43 
Heat shock temperature (OC) 
Figure 6, C-D
 88 
AuxBl Cells  CHRCS Cells 
c  b 
A G 
ô 
'. 
<> 
Ô  <> 
0 
.' 
37°C 
0 
~ 
10' 
C 
B 
Ô 
10'  10'  10'  10' 
H 
ë 
10' 
b 
<> 
10'  10'  10'  10' 
'0  <> 
0 
,.  , 
40°C 
" 
" 
~ 
10' 
C 
C 
C 
10'  10'  10'  10' 
'0 
10' 
è> 
C 
10'  10'  10  10' 
'0  0 
0  41°C 
0  .. 
~.  " 
... 
~ 
Cl .­
Cl) 
:::L 
1 
N 
...J 
LL 
~ 
10' 
C 
D 
c 
'0 
<:> 
0 
10'  10'  10' 
.", 0' 
.1 
10' 
42°C 
J 
~ 
10' 
C 
c 
ë 
<:> 
0 
10'  10'  10' 
'.~i'::  ~> • J'  . ;:;. 
l  ...  " 
.:~~~~: 
.. 
~' 
: .'-:i-I\~'  .". 
-;.l."  li·
-.f'·,: 
10' 
10' 
C
E-
c 
'0 
0 
10'  10'  10' 
~,.  ,-­ '; 
·1·... 
~.  , - .  ..'  , 
, 
. ';f!:··~ 
10' 
43°C 
K 
10' 
c 
'è 
'0 
<:> 
10'  10' 
:~~:~ 
i'!\(~:  .' 
.~;. 
:.~j'" 
10'  10' 
0  0 
10' 
C
F-
c 
10'  10'  10'  10' 
L 
10' 
c 
0 
10'  10'  10'  10' 
'0  ë 
ô  FCCP 
<:> 
0  0 
10'  10'  10'  10'  10'  10'  10'  10'  10'  10' 
Figure 7, A-L  FL1-Height 89 
o AuxB1 Cells  M 
125  •  CH
RC5 Cells 
cu  D AuxB1 Cells + FCCP  g  100 
cu­ •  CH
RC5 Cells + FCCP  00 
~ ~  75 
:to- l: 
o  0 
~  0  50 
'1- '1­
CU  0 
>';!!.,
:;:;  ~ 25 
-
ro
*a,c  *a,c CU a::  0 ;---------,----,------,-----------,--------, 
37  40  41 42  43 
Heat shock temperature (OC) 
Figure 7, M
 90 
A  Mitochondrial Cytochrome c Expression 
AuxB1 CeUs 
GAPDH 
37 40  41  42  43 
Heat shock temperature (OC) 
B 
.~  :=-250 
c:::  e  D AuxB1 CeUs 0  ....
'in  g200 
tJ)  0  •  CHRCS CeUs 
~'t-
C.  0  150 
><~ 
CI)~ 
~  .~  100 
E'C 
e g 50 
.c::::J: 
u  0  o 0  ....,....  0  +----'-'-~ 
~.-
u E  37  40  41  42 43 
Heat shock temperature (OC) 
Figure 8, A-B
 91 
C  Cytosolic Cytochrome c Expression---....., 
AuxB1 CeUs 
37 40  41  42  43 
Heat shock temperature (OC) 
D 
.2  ~250 
en  L­ [J AuxB1 CeUs  en'"  *a e 5200 
Q.CJ  •  CHRCS CeUs 
><~ 
CJ)  0 
CJ  ~ 150
 
CJ)~
 
~  ~100 
L- 0
J:.., 
.., g ~  50 
~r::::
U  .­
37 40  41  42 43 
Heat shock temperature (OC) 
Figure 8, C-O
 92 
A 
400 
... .-
~
>- 300 +:0 o  :10­
~'E 
en  0  200 1 0 
(1)'t­
CI)  0 
C'O 
o.~ 
CI)~  100 
C'O 
U 
o AuxB1  Cells 
**a 
•  CHRCS  Cells 
0+-------.------------,---------,-----,-------, 
37 40  41  42  43 
Heat shock temperature (OC) 
Figure 9, A
 93 
A  Bid 
8 
::I: 
C 
6  D AuxB1  Cells 
a. 
<t 
4  .... 
...  •  CH
RC5 Cells 
Cl  2  · .... 
0 ..., 
C 
0 
0 .­
tn  B tn 
Cl)  6 -
Bax  C 
10 
Cytochrome c 
0­
><
Cl)  4 
8 
6 
C  .-
Cl) ..., 
0-
2  · .. 
.. · ... 
4 
2 
... 
0­ .... 
0  0 
0  - Cl)  D  Apaf-l  E  Procaspase-9 
:> 
Cl) -
12  2 
10 
Cl)  1,5 
:> .­ ..., 
ca -
8 
6  ... 
Cl)
a:: 
4 
2 
0,5 
..... 
0  0 
Figure 10, A-E
 94 
A
 
o AuxB1  Cells 
400  *a 
•  CH
RC5 Cells 
+'" 's: 
~ 
-300 
:;::  0  o  Jo..
<tE 
et)  0200 
1 0 
CU't­
(/J  0 
1
!~  0: 1,----------,------------,----------,-----------,----------, 
37 40  41  42 43 
B  Heat shock temperature CC) 
200 
*a 
+'" 's: 
~ 
_ 150 
~O  o  Jo..
<tE 
r--- 0  100 
1 0 
CU't- *b
 
~  0
 
a.~  50
 
(/J~  ca 
U 
0+---------,-----------.---,----------.-----------. 
37 40  41 42 43 
Heat shock temperature CC) 
Figure 11, A-B --
95 
A  Whole Cel! PARP Expression 
AuxB1 Cells 
GAPDH 
37  40  41  42 43
 
Heat shock temperature (OC)
 
B  c 
.2 150  0  AuxB1 Cells 
tn 
tn 
Q)  •  CHRCS Cells 
~- 0.­
~ g100 
_c 
m 0 
C  CJ 
~'t-
<D  0  ,....  ~  50 
,....0
c.  a:: 
ct  c.  37 40  41  42 43 
Heat shock temperature eC) 
Figure 12, A-B
 96 
C  Whole Cel! ICAD Expression 
37 
D 
125 
r:::: 
0- 100 
'(i)  (5 
(J')  ~ 
G)'"  ... C  75 
0. 0 
><  0 
G)'+­ 50 Q  0 
<1,'#
U- 25 
AuxB1 Cells 
GAPDH 
40  41  42 43 
Heat shock temperature CC) 
D AuxB1 Cells 
•  CHRCS Cells 
37 40  41 42 43
 
Heat shock temperature (OC)
 
Figure 12, C-D
 98 
l:  H  Long PARP  1  ICAD 
.- ::I: 
5 oS:!  C 1 
Oa.
4 0.« _C' 
3 
'i -;;  0,5 
o 0 
2 
~  0 
CI)  'Cil  ....  .... >  li) •_  CI)
1ü  a.  0 +------"--------'-----.----­ o+------'-----'-----.---­
-X 
~  CI) 
D AuxB1  Cells 
•  CHRCS Cells 
Figure 13, H-I
 
Il 
L FL1-Height 
Figure 14, A-J 100 
K 
o AuxB1 Cells 80  *a,b,c 
..­ *a,b,C
~  •  CHRCS Cells o- III *a,b 'in  60 
o
Q.  - o 
-
~ 
o 
40 
(1J 
0'1  *a 
oS  20 c 
(1J 
o 
:t..
 
(1J
 
c..  0 +---------,----,--------,---------,.---, 
37 40  41  42 43 
Heat shock temperature (OC) 
Figure 14, K
 BI
 
Cells
 
CS
 
Cells
 
BI CeIls
 
With Fas
 
Antagonist
 
CS Cells
 
With Fas
 
Antagonist
 
....... 
o  ....... 
AI 
. 
BI 
40°C 
Cl 
41°C 
DI 
•  . 
El 
• 
. , 
. 
A2  B2  C2·  D2 
'\ 
. . 
~2.
 
. , 
1:1I\  "  .. 
.. 
A3  83  C3.  113  .  1<:3 
A4  84  C4  .  04  .  E4  . 
Figure 15, A-E
 102 
F  - ';!2. -
0  •  AuxB1  Cells 
.-
(J)
(J)  50  •  CHRCS Cells
 
0
 
+'"  *a,b,c 
C.  o AuxB1  Cells with Fas antagonist
 
0  40
  c.  o CHRCS Cells with Fas antagonist «  *a 
III- *a,b,c 0  30 
(1) 
Cl  ca 
+'" 20 
c: 
(1)
 
(J
 
~  10 (1) 
Il. 
0 
37 40  41  42 43 
Heat shock temperature rC) 
G  - ~  0- 1/) 25 .­
1/) 
0 
lo. 
()  20  *a 
Q) 
Z 
't­ 15 0 
Q)
 
C')
 
ca  10 ...  c 
«) 
0 
lo.  5
«) 
a. 
0 
37 40  41  42 43 
Heat shock temperature (OC) 
Figure 15, F-G 103 
FIGURE LEGENDS 
Figure 1: 
Heat  shock  induced  translocation  of FADD  from  the  cytoplasm  to  plasma 
membrane.  Drug-sensitive  AuxB1  cells  (0)  and  MDR  CHRCS  cells  (.) were 
exposed to  1 h heat shock at the indicated temperatures (40-43°C) relative to controls 
at 3rc.  Levels of expression of FADD (30  kDa) protein were expressed relative to 
untreated  control  AuxB 1 cells  (3rC) designated  as  100%.  Purity  of  subcellular 
fractionations  was  confilmed  using  antibodies  against  cytochrome  oxidase  (1), 
GSTnl  (2), and calnexin (3), specifie to  mitochondrial, cytoplasmic, and  microsomal 
fractions,  respectively (E).  Each  blot is  representative of at  least three independent 
experiments.  The  data  represent  means  ±  SEM  of  at  least  three  independent 
experiments and significance is represented by p < O.OS  (*).  (a) significant difference 
for  CHRCS  and  heated  AuxB 1 cells from  experiment control (AuxB 1 cells at  37°C). 
(b)  significant difference between AuxB1  and  CHRCS  cells at  the  specifie treatment 
temperature.  (c) significant difference for heated CHRCS  from same cell  line control 
(CHRCS cells at 37°C). 
Figure 2: 
Heat shock induced activation of initiator caspase-8.  Cells  were exposed to  1 h 
heat  shock  at  the  indicated  temperatures  (40-43°C).  Levels  of  total  cellular 
expression  of procaspase-8  (5S  kDa)  protein  (A-B)  in  AuxB 1 cells  (0) and  MDR 
CHRCS  cells  (.) are  expressed  relative  to  untreated  AuxB 1 control  cells  (37°C). 
Each blot is representative of at least three independent experiments.  Levels of Vmax 
for caspase-8 activity in  AuxB1  cells (0) and  MDR CHR C5  cells (.) are expressed 
relative  to  untreated  AuxB1  control  cells  (3rC), designated  as  1.0  (C).  The data 
represent means ± SEM of at least three independent experiments and significance is 
represented by p < O.OS  (*) and p < 0.001  (**).  (a) significant difference for CHRCS 104 
and  heated  AuxB 1  cells  from  experiment  control  (AuxB 1  cells  at  37°C).  (b) 
significant  difference  between  AuxB 1  and  CHRCS  cells  at  the  specifie  treatment 
temperature.  (c) significant difference for heated CHRCS from same cellline control 
(CHRCS cells at 37°C).  When not shown, error bars lie within the symbol. 
Figure 3:
 
Heat shock induced activation of initiator caspases-IO and -2.  Levels of caspase­
10  (A)  and  caspase-2  (B)  activity  in  AuxB 1  (0)  and  CHRCS  cells  (.)  were 
detennined by an  enzyme activity assay using caspase-lO and  -2 substrates.  Both 
caspase  activity  levels  in  CHRCS  and  AuxBl  cells  were  expressed  relative  to 
untreated  AuxB 1  (37°C).  The  data  represent  means  ±  SEM  of  at  least  three 
independent  experiments  and  significance  is  represented  by  p  <  0.05  (*).  (a) 
significant difference for  CHRCS  and  heated AuxB 1 cells from  ex periment control 
(AuxB 1 cells at 37°C).  (b) significant difference between AuxB 1 and CHRCS cells at 
the  specifie  treatment  temperature.  When  not  shown,  error  bars  lie  within  the 
symbol. 
Figure 4: 
Comparison of endogenous  expression  of extrinsic  apoptotic  pathway  protein 
levels  between  drug-sensitive  AuxBl and  MDR  CHRCS  celIs.  Confluent drug­
sensitive AuxB 1 cells (0) and MDR CHRCS  cells (.) were harvested and  the total 
cellular levels  of protein  expression of Fas  receptor (A), FADD (B), Procaspase-8 
(C),  c-FLIPs  (D),  c-FLIPL  (E)  were measured  by Western  blot (not shown).  The 
quantitative data are shown for  blots  and represent means ± SEM of at  least three 
independent experiments. lOS 
Figure 5: 
Heat  shock  induced  c1eavage  of  pro-apoptotic  Bid  in  the  cytoplasm  and 
translocation of truncated-Bid  to  the mitochondria.  Drug-sensitive AuxB 1 cells 
(0) and MDR CRRCS  cells (.) were  exposed to  1  h  heat  shock at  the  indicated 
temperatures  (40-43°C).  Levels  of  expression  of  Bid  and  tBid  proteins  were 
determined by Western blot.  Expression of Bid was measured in  the cytosol (A, B) 
and expression of tBid in  the mitochondria (C, D).  Bid (21  kDa) and tBid (14 kDa) 
levels  in  CRRCS  and AuxB 1 cells were expressed relative to  the untreated  AuxB 1 
control (37°C).  Each blot is representative of at least three independent experiments. 
The  data  represent  means ± SEM of at  least  three  independent  experiments  and 
significance is  represented by p < O.OS  (*).  (a) significant difference for CRRCS and 
heated AuxB 1 cells from experiment control  (AuxB 1 ceJls at 37°C).  (c) significant 
difference for heated CRRCS from same cell line control (CRRCS cells at 37°C). 
Figure 6: 
Heat shock induced  translocation of pro-apoptotic Bax from  the cytoplasm to 
mitochondria.  Drug-sensitive AuxB 1 cells (0) and MDR CRRCS  cells (.) were 
exposed  to  1  h  heat  shock  at  the  indicated  temperatures  (40-43°C).  Levels  of 
expression of Bax protein were determined by Western blot.  Expression of Bax was 
measured in  the cytosol (A, B) and in  the mitochondria (C, D).  Bax (21  kDa) levels 
in CRRCS and AuxB 1 cells were expressed relative to untreated AuxB 1 control cells 
(37°C).  Each blot is  representative of at least three independent experiments.  The 
data  represent  means  ±  SEM  of  at  least  three  independent  experiments  and 
significance  is  represented  by  p  <  O.OS  (*)  and  p  <  0.001  (**).  (a)  significant 
difference for CHRCS  and heated AuxBl cells from experiment control (AuxBl cells 
at 37°C).  (c)  significant difference for heated CHRCS  from  same cell  line control 
(CRRCS cells at 37°C). 106 
Figure 7: 
Mitochondrial  membrane  potential  in  response  to  heat  shock.  Mitochondrial 
membrane  potential  was  measured  by  flow  cytometry  using  JC-1  staining.  Drug­
sensitive AuxB 1 cells (A-E) and MDR CHRCS cells (G-K)  were exposed to  1 h heat 
shock at  the indicated temperatures (40-43°C) with FCCP as  positive control (F and 
L, respectively) as represented by the FACS Scan dot plots.  The relative fluorescence 
for mitochondrial membrane potential for AuxB 1 (0) and  CHRCS cells (.) (M)  was 
expressed relative to untreated AuxB1 control cells (37°C).  The data represent means 
± SEM of at least three independent experiments and significance is  represented by p 
< O.OS  (*)  and  p < 0.001  (**).  (a)  significant  difference  for  CHRCS  and  heated 
AuxB1  cells  from  experiment  control  (AuxB1  cells  at  37°C).  (c)  significant 
difference for heated CHRCS from same cell line control (CHRCS cells at 3rC). 
Figure 8: 
Heat  shock  induced  release  of  cytochrome  c  from  the  mitochondria  into 
cytoplasm.  Drug-sensitive  AuxB1  cells  (0)  and  MDR  CHRCS  cells  (.) were 
exposed  to  1  h  heat  shock  at  the  indicated  temperatures  (40-43°C).  Levels  of 
expression of cytochrome c protein were determined by Western blot.  Expression of 
cytochrome c was  measured  in  the  mitochondria  (A,  B)  and  in  the  cytosol  (C,  D). 
Cytochrome c (14 kDa) levels in  CHRCS  and AuxB 1 cells were expressed relative to 
the  untreated  AuxB 1 control  (37°C).  Each  blot  is  representative  of  at  least  three 
independent  experiments.  The  data  represent  means  ±  SEM  of  at  least  three 
independent experiments  and  significance  is  represented  by  p < O.OS  (*)  and  p < 
0.001  (**).  (a)  significant  difference  for  CHRCS  and  heated  AuxB 1 cells  from 
experiment control (AuxB1  cells at 37°C).  (b)  significant difference between AuxB 1 
and  CHRCS  cells at the specific treatment temperature.  (c)  significant difference for 
heated CHRCS from same cell line control (CHRCS cells at 37°C). 107 
Figure 9: 
Heat shock induced activation of initiator caspase-9.  CHO cells were exposed to  1 
h heat shock at the indicated temperatures (40-43°C).  Levels of caspase-9 activity in 
AuxBl (0) and MDR CHRCS cells (.) were determined by an enzyme activity assay 
using caspase-9 substrate, Ac-LEHD-AFC.  The data represent means ± SEM of at 
least three independent experiments and significance is  represented by p < 0.05  (*) 
and  p < 0.001  (**).  (a) significant difference for CHRCS  and  heated AuxB 1 cells 
from  experiment control  (AuxB 1  cells  at  37°C).  When  not  shown,  error bars  lie 
within the symbol. 
Figure 10: 
Comparison of endogenous expression of intrinsic apoptotic pathway protein 
levels  between drug-sensitive AuxBl and MDR CHRCS  cells.  Confluent drug­
sensiti ve  AuxB 1 ceUs  (0) and MDR CHRCS  ceUs  (.) were harvested and  the  total 
cellular levels of protein expression of Bid (A), Bax (B), Cytochrome c (C), Apaf-1 
(D), Procaspase-9 (E) were measured by Westem blot (not shown).  The quantitative 
data are shown for blots  and  represent means ± SEM of at  least three independent 
experiments. 
Figure 11: 
Heat shock induced activation of effector caspases-3 and -7.  CHO ceUs  were 
exposed to 2 h heat shock at the indicated temperatures (40-43°C).  Levels of caspase 
activity in AuxBl (0) and CHRCS  ceUs (.) were determined by an enzyme activity 
assay  using  caspase-3  substrate,  Ac-Asp-Glu-Val-Asp-AMC  (A)  and  caspase-7 
substrate, MCA-VDQVDGWK(DNP)-NH2 (B).  The caspase activity levels in  both 
cell  lines  were expressed relative  to  untreated  AuxB 1  (37°C).  The data  represent 
means  ±  SEM  of  at  least  three  independent  experiments  and  significance  is 
represented by p < 0.05 (*).  (a) significant difference for CHRCS and heated AuxB 1 108 
cells  from  experiment  control  (AuxBl  cells  at  37°C).  (b)  significant  difference 
between  AuxB 1  and  CHRCS  cells  at  the  specifie  treatment  temperature.  (c) 
significant difference for heated CHRCS from same cell line control (CHRCS  cells at 
3rC). When not shown, error bars lie within the symbol. 
Figure 12: 
Reat shock induced cleavage of caspase-3 substrates PARP and ICAD.  CHO 
cells were exposed to 2 h heat shock at the indicated temperatures (40-43°C).  Levels 
of expression of PARP and ICAD proteins in  AuxBl cells (0) and CHRCS cells (.) 
were detennined by Western blot.  Expression of PARP (116 kDa) (A-B) and ICAD 
(47 kDa) (C-D) protein levels in CHRCS and AuxBl cells was measured in  whole cell 
lysates and  expressed relati ve  to  the untreated AuxB 1 control (37°C).  Each  blot  is 
representative of at least three independent experiments.  The data represent means ± 
SEM of at least three independent experiments and significance is  represented by p < 
O.OS  (*).  (a)  significant  difference  for  CHRCS  and  heated  AuxB 1  cells  from 
experiment  control  (AuxBl  ceUs  at  37°C).  (c)  significant  difference  for  heated 
CHRCS from same cell line control (CHRCS cells at 37°C). 
Figure 13: 
Comparison  of endogenous  expression  of  apoptotic  execution  protein  levels 
between drug-sensitive AuxBl and MDR CRRCS cells.  Confluent drug-sensiti ve 
AuxB 1 cells (0) and  MDR CHRCS  cells (.) were harvested  and  the total  cellular 
levels of protein expression of Procaspase-3 (A), c-IAPI  (B), c-IAP2 (C),  Survivin 
(D),  HSP27  (E),  HSP90  (F),  HSP70  (G),  Long  PARP  (H)  and  ICAD  (1)  were 
measured by Western blot (not shown).  The quantitative data are shown for blots and 
represent means ± SEM of at least three independent experiments. 109 
Figure 14:
 
Heat shock induced apoptosis  in  AuxBl and CH
RC5  cells  via  flow  cytometry.
 
Apoptosis and  necrosis  levels  were  measured by  flow  cytometry using Annexin  V­

FITC staining (FLI-Channel) and PI uptake (FL3-Channel).  Drug-sensitive AuxB 1
 
cells  (A-E)  and  MDR  CRRCS  cells  (F-J)  were  exposed  to  1  h  heat  shock  at  the
 
indicated  temperatures  (40-43°C).  Upper  right  quadrant,  late  apoptosis/early
 
necrosis;  lower  right  quadrant,  early  apoptosis;  upper  left  quadrant  necrosis.
 
Percentages  of apoptosis  (K)  in  AuxBl  (0) and  CRRCS  cells  (.) are  expressed
 
relative to the untreated AuxB 1 control (3rC).  The data represent means ± SEM of
 
at least three independent experiments and significance is represented by p < O.OS  (*).
 
(a) significant difference for CRRCS and heated AuxB 1 ceUs from experiment control 
(AuxBl cells at 37°C).  (b) significant difference between AuxBI and CRRCS cells at 
the specifie treatment temperature.  (c) significant difference for heated CRRCS from 
same cellline control (CRRCS ceUs at 37°C). 
Figure 15: 
Heat  shock  induced  apoptosis  in  AuxBl  and  CH
RC5  cells  via  fluorescence 
microscopy.  Apoptosis  and  necrosis  levels  were  measured  by  fluorescence 
microscopy using Roechst 332S8 and PI staining.  Drug-sensitive AuxB 1 cells (AI,3­
EI,3) and  .rvIDR  CRRCS  ceUs  (A2,4-E2,4)  were  exposed to  2  h  heat shock at  the 
indicated temperatures (40-43°C).  Percentages of apoptosis (F)  and necrosis (G)  in 
AuxB1 (.) and  CRRCS  ceUs  (.) are  expressed  relative  to  the  untreated  AuxB1 
control (3rC).  A set of AuxB 1 (0) and CRRCS cells (0) were treated with FaslFasL 
antagonist  in  addition  to  heat.  The data represent means ± SEM of at  least three 
independent  experiments  and  significance  is  represented  by  p  <  O.OS  (*).  (a) 
significant difference for CRRCS  and  heated  AuxBI  cells from experiment control 
(AuxB 1 cells at 37°C).  (b) significant difference between AuxB 1 and CRRCS cells at 110 
the specifie treatment temperature.  (c) significant difference for heated CHRCS from 
same ceilline control (CHRCS ceUs at 37°C). CHAPTER 4:  CONCLUSION 
Cancer  represents  one  of the  most  common  causes  of death  in  developed 
countlies today.  The battle against cancer is  made difficult by the  development of 
cellular  mechanisms  to  evade  death  by  contemporary  treatments.  Chemotherapy 
represents  one  such  classical  treatment  of cancer.  The development of MDR  by 
tumour  cells  constitutes  a  major  obstacle  in  the  use  of  chemotherapy.  Thus, 
understanding  the  molecular  mechanisms  of MDR  and  being  able  to  once  again 
render  these  cells  sensitive  to  chemotherapeutic  drugs  symbolizes  a  great  leap 
forward  in  this field  and would maximize the success of patient treatment methods. 
Some strategies for sensitizing MDR cells to chemotherapeutic drugs already exist, 
involving chemosensitizers such as cyclosporin A and verapamil, nevertheless, their 
use  IS  Iimited  by  their  toxicity  and  deleterious  pharmacokinetic  and 
pharmacodynamic effects.  However,  the  use of heat  shock or hyperthermia is  an 
MDR sensitizing approach  that  may represent a  promising avenue of reversing the 
effects of MDR. 
Research  on  combination  therapy  using  heat  shock with  either radiation  or 
chemotherapy  has  shown  a  high  success  rate  in  improvement of tumour response 
(Wust et al., 2002).  Severa! recent c1inica! studies demonstrated positive responses of 
tumours with these types of combination treatments with higher patient survival rates 
(Jones et al., 2005; De Wit et aL,  1999; van der Zee et aL,  2000; Isse!s et aL,  2001; 
Wendtneret al., 2001; Hindebrandt et aL, 2004; Fraker, 2004). 
Findings from  severa]  in  vitro  studies  indicate that  chemotherapy combined 
with  either  chemosensitizers  or  heat  shock/hyperthennia  can  reverse  the  MDR 
phenotype  mediated  by  MDR  proteins  such  as  P-GP  and  MRPI  (Bates  and 
MackiIJop,  1990; Averill and Larrivée, 1998; Dumontet et aL,  1998; AveriIJ  and Su, 
1999; Lanivée and AveriIJ, 2000; Turcotte and AveriIJ-Bates, 2001; Liu et aL,  2001; 
Sous!ova and Averill-Bates, 2004).  Yet, little is understood about the mechanisms by 112 
which  heat  shocklhyperthennia  render  MDR  cells  sensitive  to  chemotherapeutic 
agents. 
This study investigated the molecular mechanisms of heat shock induced cell 
death by apoptosis  in  CHO cells, assessing the  differences in  response to  heat shock 
that  occur  between  drug-sensitive  AuxB1  and  MDR  CHRCS  cel1s.  Whereas  many 
cellular models of MDR possess a combination of different mechanisms of resistance, 
to  the  best of our knowledge,  the CHRCS  cel1s confer their resistance to  drugs solely 
by  overexpressing  the  efflux  transpol1er  P-GP.  This  makes  the  CHRCS  cells  an 
excellent  model  to  study  the  mechanisms  of  resistance  rendered  by  P-GP.  A 
comprehensive  look  into  these  heat  shock  induced  differences  that  occur  between 
drug-sensitive AuxBl  and  MDR  CHRCS  cells can  give  insight into the  maintenance 
of resistance to  cancer treatments  by  tumour cells  and  could  unveil  potentially new 
treatments strategies.  The study found that  in  fact differences in  heat shock induced 
apoptosis  do  exist  between  AuxBl  and  P-GP overexpressing  CHRCS  cells.  These 
differences  manifest  themselves  in  variation  of response of the  two  main  apoptotic 
pathways: receptor-mediated and mitochondria mediated pathways of apoptosis.  The 
results  suggest  that  CHRCS  cells confer resistance  to  heat  shock  induced  apoptosis 
mainly via  the  receptor mediated pathway.  It has  also  been  shown  that several  key 
players  involved  in  the  mitochondria  mediated  pathway  are  found  to  be  more 
abundant  in  CHRCS  cells,  possibly  tipping  the  balance  toward  this  pathway  in 
response  to  heat.  Overall,  the  CHRCS  cells are  not  resistant  to  heat shock  induced 
apoptosis.  This suggests  that  heat shock  may  provide a useful  part of the  treatment 
for eliminating MDR tumour cells. 
Nonetheless,  when  investigating  the  molecular  mechanisms  of heat  shock 
induced  apoptosis  in  MDR  cells,  other  mechanisms  of cell  death,  independent  of 
caspases,  must  be  considered.  These  alternative  types  of cel1  death  do  not  occur 
under  physiological  conditions  but  may  be  induced  by,  for  ex ample,  TNP-ex  or 
chemotherapeutic drugs (Jaattela, 2004).  Whether caspase-dependent or 113 
-independent,  the  various  types  of regulated  cell  death  are  ail  executed  by  active 
cellular processes that can  be  interrupted  by  interfering with  intracellular signalling. 
This is the main difference between these regulated types of cell death and accidentai 
necrosis  (Leist  and  Jaaletta,  2001).  Several  models  of caspase  independent death 
programs  have  been  proposed.  These  include  autophagy,  paraptosis,  mitotic 
catastrophe and slow cell death.  Autophagy is characterized by sequestration of bulk 
cytoplasm and  organelles  in  double  and  multimembrane autophagic  vesicles  which 
are  then  delivered to  and  destroyed by  the  cell 's Iysosomal  system (Schweichel  and 
Merker,  1973; Clarke, 1990).  Further, cells that undergo excessive autophagy trigger 
their  death  without  the  activation  of  caspases  (Gozuacik  and  Kimchi,  2004). 
Paraptosis is  characterized  by  cytoplasmic  vacuolation  that  begins  with  progressive 
swelling of the mitochondria and endoplasmic reticulum (ER).  Typically, it does not 
involve caspase activation or any other morphological characteristics associated with 
apoptosis (Sperandio et al.,  2000).  It is  thought to  be  mediated by  MAPKs and can 
be  triggered  by  the  TNF receptor family  member, TAl/TROY and  the  insulin-like 
growth factor l receptor (Sperandio et  al.,  2004; Wang et  al.,  2004).  Another death 
pathway  is  mitotic  catastrophe,  which  is  triggered  by  mitotic  failure  caused  by 
defective  cell  cycle  checkpoints  and  the  development  of  aneuploid  cells  that 
eventually die.  It can be triggered by agents that stabilize or destabilize microtubules 
and/or cause  DNA  damage.  Cells  that  die  by  this  pathway  do  so  either during  or 
close  to  metaphase  in  a p53-independent  manner,  or  in  a  partially  p53  dependent 
manner after faiJed mitosis by activation of a polyploidy checkpoint (Roninson et al., 
2001).  It  is  not  yet  fully  understood  whether  mitotic  catastrophe  represents  a 
completely caspase-independent œil death  pathway since  it  has  been  reported  to  be 
accompanied  by  mitochondrial  membrane  penneabilization  and  caspase  activation 
(Castedo et al., 2004).  However, it has  been argued that it is fundamentally different 
from  apoptosis  since  caspase  inhibition  and  Bcl-2  overexpression  fail  to  prevent 
mitotic catastrophe (Lock  and  Stribinskiene,  1996;  Roninson, 2001).  Finally, slow 114 
cell  death  has  been  described  to  represent  a  delayed  type  of regulated  cell  death, 
which occurs when caspases are inhibited or absent (Blagosklonny, 2000). 
Yet  despite  the  numerous  types  of regulated  cell  death,  making  exclusive 
definitions is difficult and would not be accurate as there is  much crosstalk and many 
shared signalling pathways between the various death programs.  The mitochondria, 
lysosomes and ER are the main  players involved in  the different types of regulated 
cell  death  in  a  variety  of ways.  Firstly,  the  involvement of the  mitochondria  in 
apoptotic cell death  is  through  the release of toxic  proteins from  the  mitochondrial 
intermembrane  space  upon  the  permeabilization  of the  outer  membrane.  This  is 
tightly controlled by the Bcl-2 protein family members, which includes both pro- and 
anti-apoptotic  proteins.  Proteins  which are released from  the  mitochondria include 
cytochrome c,  endonuclease Gand AIF.  Cytochrome c  is  mostly  associated with 
forming  the  apoptosome,  which  serves  to  acti vate  caspase-9  and  subsequently 
effector caspases.  However, endonuclease G  is  a protease, which is  able  to  induce 
caspase-independent  DNA  fragmentation,  most  likely  through  cooperation  with 
caspase-dependent  exonucleases  and  DNase  l  to  produce  intemucleosomal  DNA 
fragments  under  physiological  conditions  (Li  et  al.,  2001;  Widlak  et  al.,  2001). 
Apoptosis  inducing  factor  (AIF)  is  normally  found  in  the  mitochondrial 
intermembrane  space  and  performs  an  oxydoreductase  function  (Miramar  et  al., 
2001).  Upon being released into the cytoplasm it translocates to the nucleus where it 
is  involved  in  triggering  peripheral  chromatin  condensation  and  high  molecular 
weight (50 kb) DNA loss (Susin et al.,  1999; Loeffler et al., 2001; Yu et al., 2002). 
The  apoptogenic  effects  of  AIF  have  been  shown  to  be  alleviated  by  HSP70 
(Ravagnan et al., 2001).  It has also been shown that the lysosomal protease cathepsin 
D is  able to trigger AIF release independently of caspases (Bidere et al., 2003).  AIF 
release  can  also  be  triggered  by  excessive  calcium  influx,  which  leads  to 
overactivation of poly (ADP-ribose) polymerase-l (Yu et al.,  2002).  Further, it has 
been suggested that AIF can act as a precautionary defence in causing death in cancer 
cells with flawed caspase activation (Joseph et al., 2002; Liao and Dickson, 2003). 115 
Secondly, the  lysosomal  involvement in  cel1  death  has just recently become 
better defined and accepted as an organized set of events determining cell survival or 
death.  The  participation  of lysosomal  proteases  has  been  observed  in  cel1  death 
induced by oxidative stress, TNF-a, bile-salt and chemotherapeutic drugs (Zhao et aL, 
2001; Foghsgaard et al., 2001; Guicciardi et al., 2000; Roberts et al., 1997; Johansson 
et  al.,  2003).  The  magnitude  of lysosomal  permeabilization  and  the  amount  of 
proteolytic enzymes released into the cytoplasm are the main factors in  determining 
cell  death  type (Li  et  al.,  2000).  Several  mechanisms  have  been  proposed for the 
translocation  of  lysosomal  proteases  into  the  cytoplasm.  The  accumulation  of 
sphingosine  in  lysosomes  has  been  shown  to  facilitate  the  release  of  lysosomal 
enzymes  into  the  cytosol  (Kogedal  et  al.,  2001).  Generation  of reactive  oxygen 
species  (ROS)  can  also  induce  lysosomal  leakage  as  can  the  translocation  of pro­
apoptotic  Bcl-2  proteins  to  lysosomes,  where  they  induce  pore  formation  and 
membrane penneabilization (Roberg and Ollinger, 1998; Roberg et al.,  1999; Zhoa et 
al.,  2000).  HSP 70 has  recently been found to  promote cell  survival  by inhibiting 
lysosomal membrane permeabilization (Nylandsted et al., 2004).  The rnost cornmon 
lysosomal proteases cathepsin Band D are involved in carrying out cell death in  both 
caspase-dependent  and  -independent  manners.  Cathepsin  B  is  able  to  act  as  an 
effector protease downstream of caspases  in  sorne cells  as  weil  as  to  execute cell 
death independently of apoptotic machinery in  cancer cells (Foghsgaard et al., 2001; 
Broker et aL, 2004).  Cathepsin D has been shown to activate Bax leading to selective 
release  of  AIF  resulting  in  cel1  death  (Bidere  et  al.,  2003).  The  cleavage  and 
translocation  of pro-apoptotic  Bid has  also  been  shown  in  response  to  Iysosomal 
disruption  (Cinnan et  al.,  2004).  Thus  Iysosomal  proteases  seem  to  promote  cell 
death  via  rnitochondrial  dysfunction  and  the  subsequent  release  of rnitochondrial 
proteins.  Additionally,  it  has  been  reported  that  lysosomal  proteases  can  cleave 
caspases thus  suggesting that lysosomal  permeabilization  occurs early in  apoptosis 
(Schotte et aL,  1998; VancompemolJe et aL,  1998). 116 
Finally,  the  ER  is  crucial  in  sensing  cellular  stress  and  restoring  cellular 
homeostasis by  withholding protein synthesis and metabolism (Travers et al., 2000). 
Very severe damage to the ER results in  cell death by  the unfolded protein response, 
the  release  of  calcium  into  cytoplasm  and/or  the  induction  of  mitochondrial 
membrane  permeabilization.  The unfolded  protein  response  (UPR)  represents  the 
signalling  that  occurs  between  the  ER  and  the  nucleus  in  response  to  ER  stress 
(Schroder  and  Kaufman,  2005).  During  the  UPR,  accumulated  proteins  either 
undergo correct refolding or if unsuccessfully refolded are degraded by the ubiquitin­
proteosome  pathway.  Two  signalling  pathways  respond  to  ER  unfolded  protein 
overload: the UPR pathway, which triggers the expression of ER chaperones such as 
GRP78lBip (Schroder and Kaufman, 2005) and the activation of nuclear factor-kappa 
B  (NF-KB)  (Szczesna-Skorupa et al.,  2004).  The UPR occurs through  three  main 
mechanisms:  reduced  translation  of  misfolded  protein  (Koumenis  et  al.,  2002), 
enhanced  translation  of ER  chaperones  like  GRP78  and  GRP94  (Schroder  and 
Kaufman,  2005)  and  ER-associated  degradation  that  degrades  misfolded  proteins 
within  the ER, which finish  in  the cytoplasm with  the 26S  proteosome (Ahner and 
Brodsky,2004).  Three membrane receptors, PERK, IREI and ATF6, are involved in 
triggering the UPR to  ER stress  signalling (Sargsyan et  al.,  2004).  Damaged cells 
whose unfolded proteins exceed the threshold undergo cell death mediated by  ATF4 
and ATF6, as weil as activation of the JNKJAP-l/GaddI53-signaling pathway.  Gadd 
153  suppresses  activation  of Bcl-2  and  NF-KE.  UPR  cell  survival  or  death  is 
regulated by the balance of GRP78 and Gadd153 expression, which  is  co-regulated 
by NF-KB in accordance with the magnitude of ER stress (Kim et al., 2006). 
Moreover,  intracellular  ci+  influx  caused  by  ER  stress  results  In  the 
activation  of calpains  (Guroff,  1964).  Calpains  are  cytosolic  proteases,  which  act 
downstream of caspase activation and are in  tum inhibited by calpastatin (Wood and 
Newcomb,  1999;  Wood  et  al.,  1998).  Calpastatin  is  inactivated  by  calpain- or 
caspase-mediated cleavage (Wang, 2000).  The release of Ca
2 
+ into the cytosol leads 
to  the activation of caspase-12, which  normally resides on  the cytosolic face  of the 117 
ER, and  the subsequent activation of downstream caspases.  This is  thought to  occur 
via  translocation of Bim to  the ER (Morishima, 2004).  ER damage can  also  induce 
perrneabilization of the  mitochondrial outer membrane and the subsequent release of 
pro-apoptotic  proteins  contained  within,  inducing  the  apoptotic  pathway  (Jimbo, 
2003).  Bcl-2  family  proteins  and  Ca
2 
+  shifts  in  the  cytosol  are  believed  to  be 
involved  in  the  signalling  between  the  ER  and  mitochondria  (Annis  et  al.,  2004; 
Mattson and Chan, 2003). 
Undertaking this study, which  investigated the molecular mechanisms of heat 
shock induced apoptosis in  drug sensitive AuxB 1 and MDR CHRCS cells, aside From 
giving important insights, more importantly prompts more questions.  The study has 
shown differences between the two CHO cell types in  heat shock induced apoptosis. 
The CHRCS cells, which overexpress P-GP, appear ta confer resistance to heat shock 
via  the  receptor mediated pathway of apoptosis and  push the equilibrium toward the 
mitochondria  mediated  pathway  in  response  to  heat  shock.  These  findings  are 
important in understanding induction of cell death in MDR cells using heat shock as  a 
sensitizer  to  cancer  treatments  such  as  chemotherapy.  If the  mechanisms  of the 
response of MDR  cells  to  heat  shock can  be fully  elucidated, development of more 
tailored and successful treatments could be possible.  This study is  a comerstone first 
glance into  the  molecular mechanisms  involved  in  heat  shock induced cell  death  in 
MDR CHRCS cells which overexpress P-GP.  Nevertheless, more work lies ahead  in 
defining the  signalling pathways  involved  and  further,  formulating conclusions  that 
may be applied in design of cancer treatment in the future. REFERENCES 
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